<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7356825</article-id><article-id pub-id-type="doi">10.3390/molecules25122796</article-id><article-id pub-id-type="publisher-id">molecules-25-02796</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Antiviral Natural Products for Arbovirus Infections</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Goh</surname><given-names>Vanessa Shi Li</given-names></name><xref ref-type="aff" rid="af1-molecules-25-02796">1</xref><xref ref-type="aff" rid="af2-molecules-25-02796">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9239-0223</contrib-id><name><surname>Mok</surname><given-names>Chee-Keng</given-names></name><xref ref-type="aff" rid="af1-molecules-25-02796">1</xref><xref ref-type="aff" rid="af2-molecules-25-02796">2</xref><xref rid="c1-molecules-25-02796" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Chu</surname><given-names>Justin Jang Hann</given-names></name><xref ref-type="aff" rid="af1-molecules-25-02796">1</xref><xref ref-type="aff" rid="af2-molecules-25-02796">2</xref><xref ref-type="aff" rid="af3-molecules-25-02796">3</xref><xref rid="c1-molecules-25-02796" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-molecules-25-02796"><label>1</label>Laboratory of Molecular RNA Virology and Antiviral Strategies, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore; <email>micvgsl@nus.edu.sg</email></aff><aff id="af2-molecules-25-02796"><label>2</label>Infectious Disease Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore</aff><aff id="af3-molecules-25-02796"><label>3</label>Collaborative and Translation Unit for HFMD, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore 138673, Singapore</aff><author-notes><corresp id="c1-molecules-25-02796"><label>*</label>Correspondence: <email>mokcheekeng@nus.edu.sg</email> (C.-K.M.); <email>miccjh@nus.edu.sg</email> (J.J.H.C.)</corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>6</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2020</year></pub-date><volume>25</volume><issue>12</issue><elocation-id>2796</elocation-id><history><date date-type="received"><day>28</day><month>5</month><year>2020</year></date><date date-type="accepted"><day>15</day><month>6</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Over the course of the last 50 years, the emergence of several arboviruses have resulted in countless outbreaks globally. With a high proportion of infections occurring in tropical and subtropical regions where arthropods tend to be abundant, Asia in particular is a region that is heavily affected by arboviral diseases caused by dengue, Japanese encephalitis, West Nile, Zika, and chikungunya viruses. Major gaps in protection against the most significant emerging arboviruses remains as there are currently no antivirals available, and vaccines are only available for some. A potential source of antiviral compounds could be discovered in natural products&#x02014;such as vegetables, fruits, flowers, herbal plants, marine organisms and microorganisms&#x02014;from which various compounds have been documented to exhibit antiviral activities and are expected to have good tolerability and minimal side effects. Polyphenols and plant extracts have been extensively studied for their antiviral properties against arboviruses and have demonstrated promising results. With an abundance of natural products to screen for new antiviral compounds, it is highly optimistic that natural products will continue to play an important role in contributing to antiviral drug development and in reducing the global infection burden of arboviruses.</p></abstract><kwd-group><kwd>antiviral</kwd><kwd>natural products</kwd><kwd>arbovirus</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-25-02796"><title>1. Introduction</title><p>Arthropod-borne viruses (arboviruses) are a significant cause of human morbidity and mortality worldwide. They are a large and diverse group of viruses that are transmitted from infected to susceptible hosts by the bite of an arthropod vector, predominantly mosquitoes and ticks. More than 500 arboviruses have been identified, with approximately 150 arboviruses known to cause disease in humans [<xref rid="B1-molecules-25-02796" ref-type="bibr">1</xref>]. Most arboviruses causing human disease belong to four families: <italic>Flaviviridae</italic> (genus <italic>Flavivirus</italic>), <italic>Togaviridae</italic> (genus <italic>Alphavirus)</italic>, <italic>Peribunyaviridae</italic> (genus <italic>Orthobunyavirus)</italic>, and <italic>Phenuiviridae</italic> (genus <italic>Phlebovirus</italic>), with members of four other families, <italic>Nairoviridae</italic> (genus <italic>Orthonairovirus</italic>), <italic>Orthomyxoviridae</italic> (genus <italic>Thogotovirus</italic>), <italic>Rhabdoviridae</italic> (genus <italic>Vesiculovirus</italic>), and <italic>Reoviridae</italic> (genus <italic>Orbivirus</italic>) also contributing. Although arboviruses often cause large numbers of infections, the vast majority of cases are either asymptomatic or present as a flu-like illness. For this reason, the actual numbers of infection cases may be under-reported or misdiagnosed as other illnesses. Only a small proportion of cases progress to the more severe forms of arboviral disease that can be debilitating or potentially fatal, and usually affects young children or the elderly [<xref rid="B2-molecules-25-02796" ref-type="bibr">2</xref>,<xref rid="B3-molecules-25-02796" ref-type="bibr">3</xref>].</p><p>Over the course of the last 50 years, the emergence of several arboviruses&#x02014;notably dengue, chikungunya, and Zika&#x02014;have resulted in countless outbreaks globally, to which their geographical spread may be accelerated by rapid urbanization, deforestation, global warming, and increased international travel and trade [<xref rid="B3-molecules-25-02796" ref-type="bibr">3</xref>,<xref rid="B4-molecules-25-02796" ref-type="bibr">4</xref>,<xref rid="B5-molecules-25-02796" ref-type="bibr">5</xref>,<xref rid="B6-molecules-25-02796" ref-type="bibr">6</xref>]. These environmental and climate changes have brought people into more frequent contact with vectors, and have facilitated the expansion of vectors into new territories to cause disease [<xref rid="B2-molecules-25-02796" ref-type="bibr">2</xref>,<xref rid="B7-molecules-25-02796" ref-type="bibr">7</xref>,<xref rid="B8-molecules-25-02796" ref-type="bibr">8</xref>]. With a high proportion of infections occurring in tropical and subtropical regions where arthropods tend to be abundant, Asia in particular is a region that is heavily affected by arboviral diseases [<xref rid="B9-molecules-25-02796" ref-type="bibr">9</xref>]. The circulating arboviruses of public health concern in Asia can be classified into two groups: flaviviruses and alphaviruses. These include the dengue virus (DENV), Japanese encephalitis virus (JEV), West Nile virus (WNV), and Zika virus (ZIKV) which are flaviviruses, and chikungunya virus (CHIKV) which is an alphavirus (refer to <xref rid="molecules-25-02796-t001" ref-type="table">Table 1</xref>) [<xref rid="B10-molecules-25-02796" ref-type="bibr">10</xref>,<xref rid="B11-molecules-25-02796" ref-type="bibr">11</xref>,<xref rid="B12-molecules-25-02796" ref-type="bibr">12</xref>]. Severe clinical manifestations associated with each arbovirus mentioned herein have been observed. For instance, hemorrhagic fever in DENV infections, encephalitis in JEV and WNV infections; severe myalgia and arthralgia in CHIKV infections [<xref rid="B1-molecules-25-02796" ref-type="bibr">1</xref>]. In the case of ZIKV infections, an increased occurrence of congenital microcephaly and Guillain&#x02013;Barr&#x000e9; syndrome was reported in ZIKV outbreak areas [<xref rid="B13-molecules-25-02796" ref-type="bibr">13</xref>,<xref rid="B14-molecules-25-02796" ref-type="bibr">14</xref>].</p><p>Despite advances in drug development, there are no antivirals available for the treatment of these rapidly spreading arboviruses. Current treatment available is primarily palliative, and solely serves to alleviate patients&#x02019; symptoms without any specific antiviral activity. Although the approval of some vaccines have been obtained for use in certain countries or are still undergoing development or clinical trials, it is still essential to develop treatments for people who are unable to receive the vaccine, and to care for unvaccinated infected patients [<xref rid="B19-molecules-25-02796" ref-type="bibr">19</xref>]. Therefore, there is a desperate need for the discovery and development of potent and effective antivirals against arboviruses to reduce the infection burden which impacts millions across the globe.</p><p>A potential source of antiviral compounds could be discovered in natural products&#x02014;such as vegetables, fruits, flowers, herbal plants, marine organisms, and microorganisms&#x02014;from which various compounds have been documented to exhibit antiviral activity [<xref rid="B20-molecules-25-02796" ref-type="bibr">20</xref>,<xref rid="B21-molecules-25-02796" ref-type="bibr">21</xref>,<xref rid="B22-molecules-25-02796" ref-type="bibr">22</xref>,<xref rid="B23-molecules-25-02796" ref-type="bibr">23</xref>]. Screening natural products to discover novel antiviral compounds offers a head start on the drug discovery process, and could help to expedite the development of therapeutic and prophylactic treatment for arboviral diseases. This review article will summarize and discuss several studies on plant extracts, natural compounds including semi-synthetic derivatives, and synthetic compounds that have shown to demonstrate antiviral activity against DENV, JEV, WNV, ZIKV, and CHIKV that have been published in the last decade.</p></sec><sec id="sec2-molecules-25-02796"><title>2. Flaviviruses</title><p>Flaviviruses (family <italic>Flaviviridae</italic>) are small enveloped, positive-sense single-stranded RNA viruses with a genome length of approximately 10&#x02013;11 kb. The flaviviruses are a prominent group of arboviruses which include DENV, JEV, WNV, ZIKV, and many others such as yellow fever virus and hepatitis C virus (HCV).</p><sec id="sec2dot1-molecules-25-02796"><title>2.1. Dengue Virus (DENV)</title><p>Transmitted by the <italic>Aedes aegypti</italic> and <italic>Aedes albopticus</italic> mosquitoes, DENV comprises of four antigenically related but distinct serotypes, DEN-1 to -4. According to the World Health Organization, dengue virus (DENV) is considered to be the most widespread arbovirus worldwide, with the disease endemic in more than 100 countries [<xref rid="B24-molecules-25-02796" ref-type="bibr">24</xref>]. Of the 96 million cases of DENV infections that occur annually, 70% of the disease burden is contributed by Asia alone, followed by Latin America and Africa [<xref rid="B25-molecules-25-02796" ref-type="bibr">25</xref>]. As the vast majority of cases are asymptomatic or mild, the actual numbers of dengue cases could be under-reported [<xref rid="B26-molecules-25-02796" ref-type="bibr">26</xref>]. Symptoms of dengue infection include high fever (40 &#x000b0;C), severe headache, retro-orbital pain, and muscle and joint pain. In rare cases, severe dengue may occur with serious manifestations&#x02014;including capillary leakage, fluid accumulation in tissue spaces, severe bleeding, and organ impairment&#x02014;which can be potentially fatal [<xref rid="B27-molecules-25-02796" ref-type="bibr">27</xref>]. Young children in particular are at greater risk of severe dengue as they may be less able to compensate for capillary leakage than adults [<xref rid="B2-molecules-25-02796" ref-type="bibr">2</xref>].</p><p>Dengvaxia (also known as CYD-TDV) is the first tetravalent dengue vaccine to be licensed in 2015, but its performance is dependent on the serostatus of the receiving individual [<xref rid="B28-molecules-25-02796" ref-type="bibr">28</xref>]. Clinical trials have shown that the vaccine is safe and efficacious in people who previously had a DENV infection (seropositive individuals); however, it confers a predisposition to severe dengue in those who experience their first natural dengue infection after vaccination (seronegative individuals) [<xref rid="B27-molecules-25-02796" ref-type="bibr">27</xref>,<xref rid="B29-molecules-25-02796" ref-type="bibr">29</xref>]. Therefore, it may not be suitable for everyone to receive the vaccine because of the risk involved. Currently, no specific therapeutic agent exists for dengue and treatment is mainly supportive.</p></sec><sec id="sec2dot2-molecules-25-02796"><title>2.2. Japanese Encephalitis Virus (JEV)</title><p>JEV is the leading cause of viral encephalitis in Asia with approximately 68,000 cases of infection estimated to occur annually [<xref rid="B30-molecules-25-02796" ref-type="bibr">30</xref>]. <italic>Culex</italic> spp. mosquitoes are the vectors responsible for the transmission of JEV, which occurs mainly in rural agricultural areas, often associated with irrigated rice paddies [<xref rid="B31-molecules-25-02796" ref-type="bibr">31</xref>]. The virus is maintained in a cycle between mosquitoes, pigs and/or wading water birds; humans are incidental hosts. Japanese encephalitis is primarily a disease of children, with ~75% of cases occurring in children aged below 15 years old [<xref rid="B30-molecules-25-02796" ref-type="bibr">30</xref>]. It is reported that most adults in endemic regions have natural immunity after childhood infection; however, individuals of any age may be affected [<xref rid="B30-molecules-25-02796" ref-type="bibr">30</xref>]. The vast majority of JEV infections are asymptomatic or present as a flu-like illness. JEV can effectively cross the blood&#x02013;brain barrier (BBB) to cause acute encephalitis, with severe manifestations including high fever, headache, vomiting, seizures, disorientation, coma, and ultimately death [<xref rid="B32-molecules-25-02796" ref-type="bibr">32</xref>,<xref rid="B33-molecules-25-02796" ref-type="bibr">33</xref>]. The case-fatality rate can be as high as 30% among those with encephalitis, and 50% of survivors suffer permanent intellectual, behavioural, or neurological deficits [<xref rid="B30-molecules-25-02796" ref-type="bibr">30</xref>,<xref rid="B33-molecules-25-02796" ref-type="bibr">33</xref>,<xref rid="B34-molecules-25-02796" ref-type="bibr">34</xref>].</p><p>Four main types of JE vaccines are currently in use, but the live attenuated SA14-14-2 vaccine is the most widely used vaccine in endemic countries, according to the WHO [<xref rid="B35-molecules-25-02796" ref-type="bibr">35</xref>]. SA14-14-2 is administered in a two-dose regimen, and it appears to be safe and protective as no vaccine-induced severe effects have been observed [<xref rid="B36-molecules-25-02796" ref-type="bibr">36</xref>]. Still, there is a risk of reversion of the live attenuated virus to virulence. Hence, an urgent need for a safe and effective cure for JEV infection and the development of a safer, single-dose vaccine is necessary as JEV continues to expand its activity into new territories.</p></sec><sec id="sec2dot3-molecules-25-02796"><title>2.3. West Nile Virus (WNV)</title><p>WNV is widely distributed in Africa, Europe, Australia, and Asia. Since its detection in New York City in 1999 [<xref rid="B37-molecules-25-02796" ref-type="bibr">37</xref>], it continued to spread throughout the Western hemisphere&#x02014;including other parts of USA, Canada, Mexico, and the Caribbean&#x02014;resulting in significant morbidity and mortality [<xref rid="B38-molecules-25-02796" ref-type="bibr">38</xref>]. WNV is maintained in nature in a mosquito-bird-mosquito transmission cycle, primarily involving <italic>Culex</italic> spp. mosquitoes and humans, horses, and other mammals are incidental hosts [<xref rid="B39-molecules-25-02796" ref-type="bibr">39</xref>]. Most individuals infected with WNV are asymptomatic and ~20% of infected persons will experience clinical symptoms [<xref rid="B40-molecules-25-02796" ref-type="bibr">40</xref>]. The majority of people with symptoms will develop West Nile fever, and only a small number will progress to severe West Nile neuroinvasive disease (WNND), which is potentially fatal (less than 1% of all infected people) [<xref rid="B41-molecules-25-02796" ref-type="bibr">41</xref>]. Serious manifestations of WNND include encephalitis, meningitis, and acute flaccid paralysis [<xref rid="B42-molecules-25-02796" ref-type="bibr">42</xref>]. Additionally, some patients suffer fatigue, muscle weakness, and persistent tremors, lasting weeks to years even after recovery [<xref rid="B43-molecules-25-02796" ref-type="bibr">43</xref>,<xref rid="B44-molecules-25-02796" ref-type="bibr">44</xref>,<xref rid="B45-molecules-25-02796" ref-type="bibr">45</xref>]. Unfortunately, only supportive treatment is available for patients who suffer from severe and debilitating effects of WNND. To date, vaccines against WNV have been developed for horses [<xref rid="B17-molecules-25-02796" ref-type="bibr">17</xref>,<xref rid="B18-molecules-25-02796" ref-type="bibr">18</xref>], but there are no available vaccines for human use.</p></sec><sec id="sec2dot4-molecules-25-02796"><title>2.4. Zika Virus (ZIKV)</title><p>Discovered in 1947 in the Zika forest of Uganda [<xref rid="B46-molecules-25-02796" ref-type="bibr">46</xref>], <italic>Aedes</italic> mosquitoes are the vectors responsible for ZIKV transmission. Since the 1950s, ZIKV had only been reported to be circulating in Africa and Southeast Asian countries including Indonesia, Thailand, Philippines, Malaysia, and Vietnam [<xref rid="B13-molecules-25-02796" ref-type="bibr">13</xref>]. The first ZIKV outbreak recorded outside of Africa and Asia occurred in Yap Island, Federated States of Micronesia in 2007 [<xref rid="B47-molecules-25-02796" ref-type="bibr">47</xref>]. This was followed by a larger epidemic in the French Polynesia in 2013&#x02013;2014, and ZIKV subsequently spread to other Pacific islands [<xref rid="B48-molecules-25-02796" ref-type="bibr">48</xref>,<xref rid="B49-molecules-25-02796" ref-type="bibr">49</xref>]. In 2015, ZIKV emerged for the first time in the Americas, with a massive outbreak of infections occurring in Brazil [<xref rid="B50-molecules-25-02796" ref-type="bibr">50</xref>,<xref rid="B51-molecules-25-02796" ref-type="bibr">51</xref>].</p><p>Symptoms of ZIKV infection resembles that of dengue fever, which includes fever, headache, rashes, and joint and muscle pain. Although infections are usually mild or asymptomatic, neurological disorders have been associated with ZIKV infections. An increased occurrence of congenital microcephaly resulting from abnormal brain development, as well as Guillain&#x02013;Barr&#x000e9; syndrome (GBS) and acute myelitis in adults were reported in ZIKV outbreak areas [<xref rid="B14-molecules-25-02796" ref-type="bibr">14</xref>,<xref rid="B52-molecules-25-02796" ref-type="bibr">52</xref>,<xref rid="B53-molecules-25-02796" ref-type="bibr">53</xref>,<xref rid="B54-molecules-25-02796" ref-type="bibr">54</xref>,<xref rid="B55-molecules-25-02796" ref-type="bibr">55</xref>]. Long-term consequences of microcephaly can range from mild developmental delays to severe motor and intellectual deficits, and often have poor prognosis [<xref rid="B13-molecules-25-02796" ref-type="bibr">13</xref>,<xref rid="B53-molecules-25-02796" ref-type="bibr">53</xref>]. In addition, patients who suffer from GBS experience a rapid onset of muscle weakness which may lead to incapability of walking, trouble swallowing and facial paralysis [<xref rid="B13-molecules-25-02796" ref-type="bibr">13</xref>,<xref rid="B14-molecules-25-02796" ref-type="bibr">14</xref>]. Although studies have shown that there is a strong association between these effects and ZIKV infection, its mechanism is still not well understood [<xref rid="B14-molecules-25-02796" ref-type="bibr">14</xref>,<xref rid="B52-molecules-25-02796" ref-type="bibr">52</xref>,<xref rid="B53-molecules-25-02796" ref-type="bibr">53</xref>]. There is currently no specific antiviral treatment and vaccine to protect against the devastating consequences of ZIKV infection. Therefore, there is an urgent need for the development of therapeutic and prophylactic treatment for the management of ZIKV infection, especially in pregnant women and at-risk groups who live in ZIKV-endemic regions.</p></sec></sec><sec id="sec3-molecules-25-02796"><title>3. Alphaviruses</title><p>Alphaviruses (family <italic>Togaviridae</italic>) are small enveloped, positive-sense single-stranded RNA viruses with a genome length of approximately 11&#x02013;12 kb. Arthropod-borne alphaviruses include CHIKV, Mayaro virus, Ross River virus, Semliki Forest virus, Sindbis virus, and O&#x02019;nyong&#x02019;nyong virus.</p><sec id="sec3dot1-molecules-25-02796"><title>3.1. Chikungunya Virus (CHIKV)</title><p>First isolated from an outbreak in Tanzania in 1952, Chikungunya derives its name from the Tanzanian Makonde dialect that means &#x0201c;that which bends up&#x0201d;, referring to the posture of patients afflicted with extreme joint pain, which is a distinguishing trait of the illness [<xref rid="B56-molecules-25-02796" ref-type="bibr">56</xref>,<xref rid="B57-molecules-25-02796" ref-type="bibr">57</xref>,<xref rid="B58-molecules-25-02796" ref-type="bibr">58</xref>]. Since 1952, CHIKV has caused a few sporadic outbreaks, mainly in Africa, Southeast Asia and India, many of them involving hundreds of thousands of people [<xref rid="B58-molecules-25-02796" ref-type="bibr">58</xref>,<xref rid="B59-molecules-25-02796" ref-type="bibr">59</xref>,<xref rid="B60-molecules-25-02796" ref-type="bibr">60</xref>]. CHIKV only attracted worldwide attention when it caused an explosive outbreak in 2005&#x02013;2006 on the French island of La R&#x000e9;union (population: 770,000) infecting 40% of its inhabitants and resulting in more than 250 fatalities [<xref rid="B61-molecules-25-02796" ref-type="bibr">61</xref>,<xref rid="B62-molecules-25-02796" ref-type="bibr">62</xref>]. CHIKV is transmitted by <italic>Aedes</italic> mosquitoes and causes CHIK fever, which is accompanied by headache, maculopapular rash, back pain, myalgia, and polyarthralgia [<xref rid="B57-molecules-25-02796" ref-type="bibr">57</xref>,<xref rid="B63-molecules-25-02796" ref-type="bibr">63</xref>]. Complications of CHIKV infection include respiratory failure and meningoencephalitis [<xref rid="B13-molecules-25-02796" ref-type="bibr">13</xref>]. Some patients have been reported to experience recurrent and persistent myalgia and arthralgia which last for weeks to months even after recovery, resulting in long-term disability [<xref rid="B56-molecules-25-02796" ref-type="bibr">56</xref>,<xref rid="B60-molecules-25-02796" ref-type="bibr">60</xref>,<xref rid="B64-molecules-25-02796" ref-type="bibr">64</xref>]. However, there is currently no approved antiviral treatment or vaccine for CHIKV infection; treatment is usually symptomatic [<xref rid="B65-molecules-25-02796" ref-type="bibr">65</xref>]. To date, CHIKV has been detected in more than 40 countries, including Indonesia, Thailand, Singapore, Cambodia, India, USA, Italy, and France [<xref rid="B66-molecules-25-02796" ref-type="bibr">66</xref>,<xref rid="B67-molecules-25-02796" ref-type="bibr">67</xref>,<xref rid="B68-molecules-25-02796" ref-type="bibr">68</xref>,<xref rid="B69-molecules-25-02796" ref-type="bibr">69</xref>,<xref rid="B70-molecules-25-02796" ref-type="bibr">70</xref>].</p></sec><sec id="sec3dot2-molecules-25-02796"><title>3.2. Mayaro Virus</title><p>Mayaro virus (MAYV) is a neglected tropical arbovirus known to cause sporadic outbreaks in rural communities of South America, including Brazil, Peru, Venezuela, and Bolivia [<xref rid="B71-molecules-25-02796" ref-type="bibr">71</xref>,<xref rid="B72-molecules-25-02796" ref-type="bibr">72</xref>,<xref rid="B73-molecules-25-02796" ref-type="bibr">73</xref>]. First isolated in 1954 in Trinidad, it is transmitted by forest-dwelling <italic>Hemagogus</italic> mosquitoes; however, the vector competence of the urban <italic>Ae. aegypti</italic> mosquito has been confirmed experimentally [<xref rid="B74-molecules-25-02796" ref-type="bibr">74</xref>]. Symptoms of Mayaro fever include maculopapular rash, fever, and arthralgia [<xref rid="B75-molecules-25-02796" ref-type="bibr">75</xref>]. Similar to CHIKV, persistent arthralgia in patients one year after symptom onset has been reported [<xref rid="B75-molecules-25-02796" ref-type="bibr">75</xref>]. However, its symptoms may be clinically indistinguishable from dengue and chikungunya fever, hence leading to the misdiagnosis and underestimation of the number of MAYV infection cases [<xref rid="B76-molecules-25-02796" ref-type="bibr">76</xref>,<xref rid="B77-molecules-25-02796" ref-type="bibr">77</xref>]. Due to the potential of MAYV mimicking the epidemiological progression of CHIKV, it could pose a serious threat to public health systems in many countries [<xref rid="B76-molecules-25-02796" ref-type="bibr">76</xref>]. In addition, the possibility of MAYV becoming further urbanized to spread to new territories mediated by <italic>Ae. aegypti</italic> and consequently causing large epidemics is worth noting. Therefore, increased surveillance and control plans must be considered to prepare for its possible emergence [<xref rid="B78-molecules-25-02796" ref-type="bibr">78</xref>,<xref rid="B79-molecules-25-02796" ref-type="bibr">79</xref>].</p></sec></sec><sec id="sec4-molecules-25-02796"><title>4. Natural Products as a Source of Antiviral Compounds</title><p>Medicinal plants have been used for millennia in the treatment and prevention against diseases and even until now, traditional medicine involving the use of herbal products are still widely practiced in Africa, Latin America, and China, and is gaining popularity in other countries including Australia and USA [<xref rid="B80-molecules-25-02796" ref-type="bibr">80</xref>]. As the development of antivirals from synthetic molecules require a great amount of time and effort to design and validate from scratch, the discovery of antiviral compounds from natural products offers a more economical and simple alternative as they are easily accessible from nature [<xref rid="B81-molecules-25-02796" ref-type="bibr">81</xref>,<xref rid="B82-molecules-25-02796" ref-type="bibr">82</xref>,<xref rid="B83-molecules-25-02796" ref-type="bibr">83</xref>]. Over the years, polyphenols&#x02014;which are naturally occurring compounds found in fruits, vegetables, wine, and tea&#x02014;have increasingly gained scientific interest as they have been reported to exhibit a wide range of pharmacological activities such as antiviral, anti-bacterial, antioxidant, anti-inflammatory, and anti-carcinogenic effects [<xref rid="B84-molecules-25-02796" ref-type="bibr">84</xref>,<xref rid="B85-molecules-25-02796" ref-type="bibr">85</xref>,<xref rid="B86-molecules-25-02796" ref-type="bibr">86</xref>,<xref rid="B87-molecules-25-02796" ref-type="bibr">87</xref>,<xref rid="B88-molecules-25-02796" ref-type="bibr">88</xref>]. They are secondary metabolites of plants that are involved in protecting the plant from UV radiation, microbial infection, and defence against insects [<xref rid="B89-molecules-25-02796" ref-type="bibr">89</xref>]. In food, polyphenols may contribute to the colour, flavour, odor, bitterness, astringency and oxidative stability [<xref rid="B90-molecules-25-02796" ref-type="bibr">90</xref>]. Furthermore, they are expected to have minimal side effects as they form an integral part of the human diet.</p><p>Flavonoids are an important class of polyphenols with more than 4000 varieties identified in various plant species, and can be further divided into six subclasses: flavonols, flavones, flavanones, flavanols, anthocyanin, and isoflavones [<xref rid="B89-molecules-25-02796" ref-type="bibr">89</xref>,<xref rid="B90-molecules-25-02796" ref-type="bibr">90</xref>,<xref rid="B91-molecules-25-02796" ref-type="bibr">91</xref>]. Regardless of the type of flavonoid, they are always characterized by a chromane ring bearing either a 2- or 3-phenyl ring which classifies them as a flavonoid, or an isoflavonoid, respectively [<xref rid="B20-molecules-25-02796" ref-type="bibr">20</xref>]. The complexity of chemical structures that flavonoids offer may present potential broad-spectrum antiviral activities that can target various enzymes to disrupt the viral replication cycle [<xref rid="B20-molecules-25-02796" ref-type="bibr">20</xref>,<xref rid="B23-molecules-25-02796" ref-type="bibr">23</xref>,<xref rid="B92-molecules-25-02796" ref-type="bibr">92</xref>,<xref rid="B93-molecules-25-02796" ref-type="bibr">93</xref>]. In addition, not all flavonoids are absorbed with the same efficiency as its structural variation influences the rate of absorption, metabolism, and bioavailability in the body [<xref rid="B94-molecules-25-02796" ref-type="bibr">94</xref>]. Hence, the antiviral effects of flavonoids are dependent on its bioavailability&#x02014;the proportion of active ingredient that is digested, absorbed, and metabolized through normal pathways and become available at the site of action [<xref rid="B89-molecules-25-02796" ref-type="bibr">89</xref>,<xref rid="B90-molecules-25-02796" ref-type="bibr">90</xref>]. Therefore, in vitro results do not necessarily translate into efficacy in vivo and will require modifications to the compound to improve its bioavailability, so as to further clinical development against the target viruses. Strategies to overcome the poor systemic bioavailability of compounds will be discussed later. Numerous flavonoids, as well as plant extracts, have been reported for their antiviral activities against enveloped RNA viruses, including flaviviruses and alphaviruses (refer to <xref rid="molecules-25-02796-t002" ref-type="table">Table 2</xref> and <xref rid="molecules-25-02796-t003" ref-type="table">Table 3</xref>). This review will highlight several interesting natural compounds and extracts which possess great antiviral potential.</p><sec id="sec4dot1-molecules-25-02796"><title>4.1. Antiviral Natural Compounds</title><sec id="sec4dot1dot1-molecules-25-02796"><title>4.1.1. Curcumin</title><p>Curcumin is a yellow pigment present in turmeric, a spice widely used throughout the world, and in traditional Asian and African medicine to treat a wide range of illnesses for over 4000 years. It has been shown to exhibit antioxidant, anti-inflammatory, anti-microbial, and anti-carcinogenic effects [<xref rid="B94-molecules-25-02796" ref-type="bibr">94</xref>,<xref rid="B116-molecules-25-02796" ref-type="bibr">116</xref>]. Moreover, the safety, tolerability, and non-toxicity of curcumin at high doses are well established in various human and animal models [<xref rid="B116-molecules-25-02796" ref-type="bibr">116</xref>,<xref rid="B117-molecules-25-02796" ref-type="bibr">117</xref>,<xref rid="B118-molecules-25-02796" ref-type="bibr">118</xref>,<xref rid="B119-molecules-25-02796" ref-type="bibr">119</xref>]. Besides being able to inhibit DENV, JEV, ZIKV, and CHIKV [<xref rid="B97-molecules-25-02796" ref-type="bibr">97</xref>,<xref rid="B98-molecules-25-02796" ref-type="bibr">98</xref>,<xref rid="B99-molecules-25-02796" ref-type="bibr">99</xref>], curcumin has been reported to exhibit broad-spectrum antiviral activity against several enveloped viruses including PR8 influenza virus, vaccinia virus, pseudorabies virus, Newcastle disease virus [<xref rid="B98-molecules-25-02796" ref-type="bibr">98</xref>], HCV [<xref rid="B120-molecules-25-02796" ref-type="bibr">120</xref>], and human immunodeficiency virus (HIV) [<xref rid="B121-molecules-25-02796" ref-type="bibr">121</xref>]. In contrast, the non-enveloped enterovirus-A71 (EV-A71) remained unaffected by curcumin treatment [<xref rid="B98-molecules-25-02796" ref-type="bibr">98</xref>]. In general, the specific mechanisms by which curcumin exerts its antiviral effects against arboviruses is not well understood (refer to <xref rid="molecules-25-02796-t002" ref-type="table">Table 2</xref>), but it has been proposed that the compound inhibits virus attachment to host cells [<xref rid="B99-molecules-25-02796" ref-type="bibr">99</xref>].</p><p>Although curcumin is safe and efficacious, it is not an approved therapeutic agent because of its low bioavailability, poor aqueous solubility, and complications with drug delivery, which are challenges that have yet to be overcome [<xref rid="B94-molecules-25-02796" ref-type="bibr">94</xref>,<xref rid="B116-molecules-25-02796" ref-type="bibr">116</xref>]. To improve upon curcumin&#x02019;s stability at plasma pH, Balasubramanian and co-workers (2019) generated four synthetic monoketone analogues of curcumin (curcuminoids) and tested them for their anti-DENV activity [<xref rid="B97-molecules-25-02796" ref-type="bibr">97</xref>]. Three out of four synthetic curcuminoids&#x02014;namely the acyclic, cyclopentanone, and cyclohexanone analogues of curcumin&#x02014;were shown to possess better antiviral activities with improved stability as compared to native curcumin [<xref rid="B97-molecules-25-02796" ref-type="bibr">97</xref>]. Modifications upon the chemical structure is one of the many strategies than can be employed to improve upon the bioavailability of curcumin [<xref rid="B116-molecules-25-02796" ref-type="bibr">116</xref>].</p></sec><sec id="sec4dot1dot2-molecules-25-02796"><title>4.1.2. Epigallocatechin Gallate (EGCG)</title><p>Epigallocatechin gallate (EGCG) is a flavonoid abundant in green tea and has shown to possess potent antiviral activity against HIV, influenza virus, herpes simplex virus (HSV), and HCV [<xref rid="B92-molecules-25-02796" ref-type="bibr">92</xref>,<xref rid="B101-molecules-25-02796" ref-type="bibr">101</xref>,<xref rid="B122-molecules-25-02796" ref-type="bibr">122</xref>,<xref rid="B123-molecules-25-02796" ref-type="bibr">123</xref>]. A direct virucidal effect of EGCG was observed against DENV, CHIKV, WNV, and ZIKV, but its specific mechanism is not well understood (refer to <xref rid="molecules-25-02796-t002" ref-type="table">Table 2</xref>) [<xref rid="B92-molecules-25-02796" ref-type="bibr">92</xref>,<xref rid="B100-molecules-25-02796" ref-type="bibr">100</xref>,<xref rid="B101-molecules-25-02796" ref-type="bibr">101</xref>]. Three studies have collectively suggested that EGCG exerts its antiviral effect at the early stages of viral replication, possibly by binding directly to the viral particle to inhibit host cell attachment [<xref rid="B92-molecules-25-02796" ref-type="bibr">92</xref>,<xref rid="B100-molecules-25-02796" ref-type="bibr">100</xref>,<xref rid="B101-molecules-25-02796" ref-type="bibr">101</xref>]. Carneiro and colleagues (2016) suggested that the antiviral mechanism by which EGCG exerts on ZIKV (and possibly other arboviruses) could be the same as HIV, as reported in a previous study [<xref rid="B123-molecules-25-02796" ref-type="bibr">123</xref>]. In that study, it was established that EGCG could destroy and destabilize the viral envelope phospholipids, thus leading to virus destruction [<xref rid="B123-molecules-25-02796" ref-type="bibr">123</xref>]. Despite being a natural compound, EGCG can be toxic to various cell lines at higher concentrations, but is regarded to be safe for use in healthy individuals [<xref rid="B101-molecules-25-02796" ref-type="bibr">101</xref>,<xref rid="B124-molecules-25-02796" ref-type="bibr">124</xref>]. In addition, a study in rats showed that EGCG can easily cross the placental barrier and spread to foetal tissues such as the brain, eyes, and heart [<xref rid="B125-molecules-25-02796" ref-type="bibr">125</xref>]. Together, these studies show that EGCG is a potential antiviral candidate capable of inhibiting several arboviruses, and would be especially helpful to treat or prevent neuroinvasive arboviruses like JEV, WNV, and ZIKV.</p></sec><sec id="sec4dot1dot3-molecules-25-02796"><title>4.1.3. Pinocembrin</title><p>Pinocembrin is a flavanone abundant in propolis, honey, tea, and red wine. Widely studied for its role in neurodegenerative diseases and ischemic stroke, it has neuroprotective, antioxidant, anti-inflammatory, as well as anti-microbial effects [<xref rid="B126-molecules-25-02796" ref-type="bibr">126</xref>,<xref rid="B127-molecules-25-02796" ref-type="bibr">127</xref>]. It has been shown to be able to cross the BBB because of its low molecular weight and good liposolubility in an in vitro model using cultured rat brain microvascular endothelial cells (BMECs) [<xref rid="B127-molecules-25-02796" ref-type="bibr">127</xref>,<xref rid="B128-molecules-25-02796" ref-type="bibr">128</xref>]. Recently, Lee and colleagues (2019) reported that pinocembrin is able to inhibit ZIKV infection in human placental JEG-3 and human hepatoma Huh7 cell lines. The study determined that pinocembrin acts on post-entry processes of the ZIKV replication cycle but its exact mechanism remains to be studied [<xref rid="B107-molecules-25-02796" ref-type="bibr">107</xref>]. The broad-spectrum antiviral activity of pinocembrin was also investigated in the same study using DEN-2, CHIKV, and EV-A71; significant inhibition against DEN-2 and CHIKV was demonstrated [<xref rid="B107-molecules-25-02796" ref-type="bibr">107</xref>].</p><p>A phase I clinical trial for pinocembrin as a new neuroprotective agent reported no adverse effects when 120 mg/day of pinocembrin was administered intravenously to 58 healthy adults for 5 days, which suggests that pinocembrin is safe and well-tolerated [<xref rid="B129-molecules-25-02796" ref-type="bibr">129</xref>]. In regards to using pinocembrin as an antiviral drug, more work needs to be done to validate its ability to reduce ZIKV-associated symptoms and neurodegenerative effects as well as to evaluate its safety for use in pregnant women [<xref rid="B126-molecules-25-02796" ref-type="bibr">126</xref>].</p></sec><sec id="sec4dot1dot4-molecules-25-02796"><title>4.1.4. Quinine/Quinine Sulfate</title><p>Quinine is a natural compound extracted from the bark of the Cinchona tree and is an important anti-malarial agent which has been used to treat malaria from as early as the 1600s [<xref rid="B130-molecules-25-02796" ref-type="bibr">130</xref>]. It was shown to exert antiviral activity on HSV [<xref rid="B131-molecules-25-02796" ref-type="bibr">131</xref>], influenza [<xref rid="B132-molecules-25-02796" ref-type="bibr">132</xref>], and DENV [<xref rid="B109-molecules-25-02796" ref-type="bibr">109</xref>]. A study sought to repurpose four drugs as anti-DENV drug candidates by investigating their antiviral activity in all four serotypes of DENV [<xref rid="B109-molecules-25-02796" ref-type="bibr">109</xref>]. Drug repurposing is a strategy which uses established drugs to treat diseases that lack specific therapeutic treatments as it is a faster and more cost-effective approach compared to de novo drug discovery and development [<xref rid="B133-molecules-25-02796" ref-type="bibr">133</xref>]. Of the four drugs examined, quinine markedly decreased DENV replication by inhibiting DENV RNA replication, protein synthesis, and virus production by targeting host factors; however, its specific antiviral mechanism could not be determined [<xref rid="B109-molecules-25-02796" ref-type="bibr">109</xref>]. As quinine is reported to act on host cells rather than directly upon the virion, resistance to the compound could be minimized [<xref rid="B131-molecules-25-02796" ref-type="bibr">131</xref>].</p><p>The effects of quinine in the human body is well studied as it has been in use for years, primarily for the treatment of malaria. It has been reported that quinine produces mild to severe side effects at therapeutic concentrations in malaria treatment [<xref rid="B130-molecules-25-02796" ref-type="bibr">130</xref>]. Mild symptoms include headache, nausea, and tinnitus; while more severe side effects include vertigo, vomiting, loss of vision, and marked auditory loss [<xref rid="B130-molecules-25-02796" ref-type="bibr">130</xref>]. Identifying quinine as an antiviral drug is a good starting point, but more evaluation and calibration to optimize the dose and duration of treatment to minimize prolonged exposure and its associated side effects must be performed before it can be prescribed to treat viral infections.</p></sec><sec id="sec4dot1dot5-molecules-25-02796"><title>4.1.5. Other Potential Antiviral Compounds against Arboviruses</title><p>Other natural compounds that have been reported to exhibit antiviral activities, as well as the assays performed to determine the proposed mode of action have been summarized in <xref rid="molecules-25-02796-t002" ref-type="table">Table 2</xref>. An overview of the compounds that can inhibit the different arboviruses is provided in <xref rid="molecules-25-02796-t004" ref-type="table">Table 4</xref>.</p></sec></sec><sec id="sec4dot2-molecules-25-02796"><title>4.2. Antiviral Plant Extracts</title><sec id="sec4dot2dot1-molecules-25-02796"><title>4.2.1. <italic>Psiloxylon mauritianum</italic> Extract</title><p>An indigenous medicinal plant ubiquitous in the Reunion and Mauritius Islands, <italic>Psiloxylon mauritianum</italic> is widely used in traditional medicine among the local people for dysentery and common infectious diseases [<xref rid="B113-molecules-25-02796" ref-type="bibr">113</xref>]. Given the high content of polyphenols present in <italic>P. mauritianum</italic> extract, a study evaluated its ability to inhibit ZIKV and DENV infections [<xref rid="B113-molecules-25-02796" ref-type="bibr">113</xref>]. The data showed that <italic>P. mauritianum</italic> extract was able to inhibit ZIKV attachment to the host cell surface, and was able to exert antiviral activity against four DENV serotypes [<xref rid="B113-molecules-25-02796" ref-type="bibr">113</xref>]. The plant extract displayed low toxicity and did not exert a genotoxic effect on human primary cell lines tested [<xref rid="B113-molecules-25-02796" ref-type="bibr">113</xref>]. However, more work needs to be done to identify the active compounds responsible for antiviral activity from the plant extract and to investigate its potential to be an anti-flaviviral agent.</p></sec><sec id="sec4dot2dot2-molecules-25-02796"><title>4.2.2. Silymarin Complex</title><p>Silymarin is a complex extracted from milk thistle (<italic>Silybum marianum</italic>) seeds, and its major active compound is silybin [<xref rid="B134-molecules-25-02796" ref-type="bibr">134</xref>]. Due to its antioxidant, anti-inflammatory, antifibrotic, and hepatoprotective activities, it is used as a supportive treatment for chronic liver diseases, hepatocellular carcinoma, and liver cirrhosis [<xref rid="B134-molecules-25-02796" ref-type="bibr">134</xref>]. In a two-year toxicity study of silymarin conducted in mice, no adverse side effects were reported [<xref rid="B135-molecules-25-02796" ref-type="bibr">135</xref>]. Even in humans, it is a well-tolerated compound after prolonged and high dosage use, with the most common side effects being headache and itching [<xref rid="B136-molecules-25-02796" ref-type="bibr">136</xref>]. Silymarin was shown to inhibit HCV both in vitro and in vivo by inhibiting viral entry, RNA synthesis, and viral protein expression (refer to <xref rid="molecules-25-02796-t003" ref-type="table">Table 3</xref>) [<xref rid="B137-molecules-25-02796" ref-type="bibr">137</xref>]. In a study conducted by Lani and co-workers (2015), silymarin demonstrated significant in vitro antiviral activity against CHIKV by suppressing post-entry stages of the CHIKV replication cycle and inhibit CHIKV-induced cell death [<xref rid="B114-molecules-25-02796" ref-type="bibr">114</xref>]. Additionally, silymarin has recently been reported to be able to inhibit MAYV, which is an alphavirus like CHIKV, by suppressing MAYV replication and attenuating MAYV-induced oxidative stress caused by MAYV infection [<xref rid="B115-molecules-25-02796" ref-type="bibr">115</xref>]. This suggests that there could be potential in silymarin to be a broad-spectrum antiviral drug, but its activity against other viruses will need to be investigated further.</p></sec><sec id="sec4dot2dot3-molecules-25-02796"><title>4.2.3. Other Potential Antiviral Plant Extracts against Arboviruses</title><p><xref rid="molecules-25-02796-t003" ref-type="table">Table 3</xref> lists two other plant extracts that have been reported to exhibit antiviral activity against arboviruses, as well as the assays done to determine the proposed mode of action. <italic>Aphloia theiformis</italic>, an edible indigenous plant from La R&#x000e9;union, as well as mushroom extracts derived from each of the four culinary and medicinal mushrooms, <italic>Lignosus rhinocerotis, Pleurotus giganteus, Hericium erinaceus</italic> and <italic>Schizophyllum commune</italic>. An overview of the plant extracts which can inhibit the different arboviruses is provided in <xref rid="molecules-25-02796-t005" ref-type="table">Table 5</xref>.</p></sec></sec></sec><sec id="sec5-molecules-25-02796"><title>5. Conclusions</title><p>To address the current lack of antivirals against arboviruses, great efforts to search for potential antiviral compounds against arboviruses have been made by applying various approaches, from drug repurposing to the screening of different bioactive compound libraries, as well as natural products. In particular, polyphenols&#x02014;which are naturally occurring compounds present in a wide array of fruits, vegetables, and plant parts (roots, bark, leaves and flowers)&#x02014;have increasingly gained medicinal interest as they have shown to possess numerous health benefits and broad-spectrum antiviral activities in various studies. Screening natural products to discover novel antivirals offer a more time-efficient and economical alternative to traditional drug discovery processes that involve developing drug candidates from scratch, which can be inefficient and costly. In addition, the chemical structures of the novel compounds identified to exhibit antiviral activity could be utilized as a scaffold for designing semi-synthetic or synthetic drug derivatives so as to optimise its stability, or to enhance its antiviral potency. By developing antivirals against arboviruses, therapeutic treatment can be made available to infected patients to accelerate viral clearance and to reduce disease severity [<xref rid="B138-molecules-25-02796" ref-type="bibr">138</xref>]. Other applications for anti-arboviral drug development include prophylactic or early post-exposure prophylactic treatment for people living in arbovirus endemic areas where vaccines against the arboviruses are not yet available, or for travellers visiting countries with ongoing outbreaks [<xref rid="B138-molecules-25-02796" ref-type="bibr">138</xref>].</p><p>Many antiviral candidates have been found to inhibit viral replication using in vitro approaches, and only a few have been tested in vivo. This indicates the difficulty in translating experimental results to humans, and in completing the entire drug development process [<xref rid="B139-molecules-25-02796" ref-type="bibr">139</xref>]. Nevertheless, careful evaluation must be conducted to understand the efficacy, tolerability, and safety of the drug by observing for any adverse side effects, or side effects associated with long-term exposure before using them in clinical practice. The target populations for receiving antiviral therapy will include children, elderly, and patients with pre-existing conditions, as well as pregnant women (risk of ZIKV infection) living in endemic areas, as they are especially vulnerable to the severe manifestations of arboviral diseases. In addition, further work is required to uncover the inhibition mechanisms of the antiviral candidates in order to elucidate the host or viral receptors involved in suppressing infection effectively, as well as to examine the possibility of combination therapies involving other natural compounds or established antivirals.</p><p>The low bioavailability of polyphenols in the body is one of several factors which hinder the development of antiviral drugs from natural compounds. It can be attributed to inefficient absorption in the intestine, poor water solubility, high metabolism rate, rapid systemic elimination, and remains a challenge faced by many [<xref rid="B97-molecules-25-02796" ref-type="bibr">97</xref>,<xref rid="B101-molecules-25-02796" ref-type="bibr">101</xref>,<xref rid="B108-molecules-25-02796" ref-type="bibr">108</xref>,<xref rid="B114-molecules-25-02796" ref-type="bibr">114</xref>,<xref rid="B137-molecules-25-02796" ref-type="bibr">137</xref>]. Strategies to enhance the bioavailability of compounds have been employed based on changes in drug formulation, or modification to the chemical structure. Nanoparticle, micelle, and liposome-based drug formulations which encapsulates the drug in the particles have been successful in improving bioavailability [<xref rid="B140-molecules-25-02796" ref-type="bibr">140</xref>,<xref rid="B141-molecules-25-02796" ref-type="bibr">141</xref>,<xref rid="B142-molecules-25-02796" ref-type="bibr">142</xref>,<xref rid="B143-molecules-25-02796" ref-type="bibr">143</xref>,<xref rid="B144-molecules-25-02796" ref-type="bibr">144</xref>]. Due to their small size and permeability, nanoparticles can improve delivery to membrane barriers, while micelles and liposomes can counter hydrophobicity as they can carry both hydrophilic and hydrophobic molecules [<xref rid="B94-molecules-25-02796" ref-type="bibr">94</xref>,<xref rid="B116-molecules-25-02796" ref-type="bibr">116</xref>]. In addition, modifications to the chemical structure could also improve bioavailability by adding complexes that are highly soluble in water to increase aqueous solubility and absorption in the gastrointestinal tract, or by the removal of chemical moieties to enhance stability of the molecule [<xref rid="B94-molecules-25-02796" ref-type="bibr">94</xref>,<xref rid="B97-molecules-25-02796" ref-type="bibr">97</xref>,<xref rid="B145-molecules-25-02796" ref-type="bibr">145</xref>]. For instance, curcumin A, a curcumin analogue was synthesized by removing the &#x003b2;-diketone moiety from curcumin to improve stability as its presence renders it prone to decomposition at physiological pH [<xref rid="B145-molecules-25-02796" ref-type="bibr">145</xref>]. Curcumin A was reported to withstand rapid degradation while retaining curcumin&#x02019;s antiviral activity against HIV-1 infection in cultured lymphoblastoid T cells and peripheral blood mononuclear cells [<xref rid="B145-molecules-25-02796" ref-type="bibr">145</xref>]. It was demonstrated to have improved stability in serum for up to 24 h as compared to curcumin, which is degraded by half within 10 h [<xref rid="B145-molecules-25-02796" ref-type="bibr">145</xref>].</p><p>Natural compounds are expected to have good tolerability and minimal side effects, which are desirable traits for therapeutic and prophylactic treatment. In addition to vaccine development, drugs for prophylaxis, post-exposure prophylaxis, and treatment should be developed to prevent and mitigate the severity of arboviral diseases. As natural products provide a rich source of chemical diversity and pharmacological activities, it could potentially limit antiviral resistance, and also offer flexibility of use in other treatments including cancer, cardiovascular diseases, neurodegenerative diseases, and diabetes [<xref rid="B91-molecules-25-02796" ref-type="bibr">91</xref>,<xref rid="B126-molecules-25-02796" ref-type="bibr">126</xref>,<xref rid="B146-molecules-25-02796" ref-type="bibr">146</xref>]. With an abundance of natural products to screen for new antiviral compounds, it is highly optimistic that natural products will continue to play an important role in contributing to antiviral drug development, and in reducing the infection burden that impacts millions globally.</p></sec></body><back><ack><title>Acknowledgments</title><p>We acknowledge support from NUHS Seed Fund (NUHSRO/2020/010/RO5+5/Seed-Aug/08) awarded to Chee Keng Mok. Due to the space constraints, we apologize for not being able to include all studies that have been reported.</p></ack><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-25-02796"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Young</surname><given-names>P.R.</given-names></name><name><surname>Ng</surname><given-names>L.F.P.</given-names></name><name><surname>Hall</surname><given-names>R.A.</given-names></name><name><surname>Smith</surname><given-names>D.W.</given-names></name><name><surname>Johansen</surname><given-names>C.A.</given-names></name></person-group><article-title>Chapter 14-Arbovirus Infections</article-title><source>Manson&#x02019;s Tropical Infectious Diseases</source><edition>23rd ed.</edition><person-group person-group-type="editor"><name><surname>Farrar</surname><given-names>J.</given-names></name><name><surname>Hotez</surname><given-names>P.J.</given-names></name><name><surname>Junghanss</surname><given-names>T.</given-names></name><name><surname>Kang</surname><given-names>G.</given-names></name><name><surname>Lalloo</surname><given-names>D.</given-names></name><name><surname>White</surname><given-names>N.J.</given-names></name></person-group><publisher-name>W.B. Saunders</publisher-name><publisher-loc>London, UK</publisher-loc><year>2014</year><fpage>129</fpage><lpage>161</lpage></element-citation></ref><ref id="B2-molecules-25-02796"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilder-Smith</surname><given-names>A.</given-names></name><name><surname>Ooi</surname><given-names>E.-E.</given-names></name><name><surname>Horstick</surname><given-names>O.</given-names></name><name><surname>Wills</surname><given-names>B.</given-names></name></person-group><article-title>Dengue</article-title><source>Lancet</source><year>2019</year><volume>393</volume><fpage>350</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(18)32560-1</pub-id><pub-id pub-id-type="pmid">30696575</pub-id></element-citation></ref><ref id="B3-molecules-25-02796"><label>3.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Young</surname><given-names>P.R.</given-names></name></person-group><article-title>Arboviruses: A Family on the Move</article-title><source>Dengue and Zika: Control and Antiviral Treatment Strategies</source><person-group person-group-type="editor"><name><surname>Hilgenfeld</surname><given-names>R.</given-names></name><name><surname>Vasudevan</surname><given-names>S.G.</given-names></name></person-group><publisher-name>Springer</publisher-name><publisher-loc>Singapore</publisher-loc><year>2018</year><fpage>1</fpage><lpage>10</lpage></element-citation></ref><ref id="B4-molecules-25-02796"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilder-Smith</surname><given-names>A.</given-names></name><name><surname>Gubler</surname><given-names>D.J.</given-names></name><name><surname>Weaver</surname><given-names>S.C.</given-names></name><name><surname>Monath</surname><given-names>T.P.</given-names></name><name><surname>Heymann</surname><given-names>D.L.</given-names></name><name><surname>Scott</surname><given-names>T.W.</given-names></name></person-group><article-title>Epidemic arboviral diseases: Priorities for research and public health</article-title><source>Lancet Infect. Dis.</source><year>2017</year><volume>17</volume><fpage>e101</fpage><lpage>e106</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(16)30518-7</pub-id><pub-id pub-id-type="pmid">28011234</pub-id></element-citation></ref><ref id="B5-molecules-25-02796"><label>5.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Marchi</surname><given-names>S.</given-names></name><name><surname>Trombetta</surname><given-names>C.M.</given-names></name><name><surname>Montomoli</surname><given-names>E.</given-names></name></person-group><article-title>Emerging and Re-emerging Arboviral Diseases as a Global Health Problem</article-title><source>Public Health-Emerging and Re-emerging Issues</source><person-group person-group-type="editor"><name><surname>Majumder</surname><given-names>M.A.A.</given-names></name><name><surname>Russel</surname><given-names>K.</given-names></name><name><surname>Sayeeda</surname><given-names>R.</given-names></name></person-group><publisher-name>InTech</publisher-name><publisher-loc>London, UK</publisher-loc><year>2018</year><pub-id pub-id-type="doi">10.5772/intechopen.77382</pub-id></element-citation></ref><ref id="B6-molecules-25-02796"><label>6.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>Dengue Guidelines for Diagnosis, Treatment, Prevention and Control</source><publisher-name>WHO</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2009</year></element-citation></ref><ref id="B7-molecules-25-02796"><label>7.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hanley</surname><given-names>K.A.</given-names></name><name><surname>Weaver</surname><given-names>S.C.</given-names></name></person-group><article-title>Chapter 16-Arbovirus Evolution</article-title><source>Origin and Evolution of Viruses</source><edition>2nd ed.</edition><person-group person-group-type="editor"><name><surname>Domingo</surname><given-names>E.</given-names></name><name><surname>Parrish</surname><given-names>C.R.</given-names></name><name><surname>Holland</surname><given-names>J.J.</given-names></name></person-group><publisher-name>Academic Press</publisher-name><publisher-loc>London, UK</publisher-loc><year>2008</year><fpage>351</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-374153-0.00016-3</pub-id></element-citation></ref><ref id="B8-molecules-25-02796"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>S.C.</given-names></name><name><surname>Reisen</surname><given-names>W.K.</given-names></name></person-group><article-title>Present and future arboviral threats</article-title><source>Antivir. Res.</source><year>2010</year><volume>85</volume><fpage>328</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2009.10.008</pub-id><?supplied-pmid 19857523?><pub-id pub-id-type="pmid">19857523</pub-id></element-citation></ref><ref id="B9-molecules-25-02796"><label>9.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><article-title>Fact Sheet: Dengue and Severe Dengue</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue">https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-04-01">(accessed on 1 April 2020)</date-in-citation></element-citation></ref><ref id="B10-molecules-25-02796"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gould</surname><given-names>E.</given-names></name><name><surname>Pettersson</surname><given-names>J.</given-names></name><name><surname>Higgs</surname><given-names>S.</given-names></name><name><surname>Charrel</surname><given-names>R.</given-names></name><name><surname>De Lamballerie</surname><given-names>X.</given-names></name></person-group><article-title>Emerging arboviruses: Why today?</article-title><source>One Health</source><year>2017</year><volume>4</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.onehlt.2017.06.001</pub-id><?supplied-pmid 28785601?><pub-id pub-id-type="pmid">28785601</pub-id></element-citation></ref><ref id="B11-molecules-25-02796"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dash</surname><given-names>A.P.</given-names></name><name><surname>Bhatia</surname><given-names>R.</given-names></name><name><surname>Sunyoto</surname><given-names>T.</given-names></name><name><surname>Mourya</surname><given-names>D.T.</given-names></name></person-group><article-title>Emerging and re-emerging arboviral diseases in Southeast Asia</article-title><source>J. Vector Borne Dis.</source><year>2013</year><volume>50</volume><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">23995308</pub-id></element-citation></ref><ref id="B12-molecules-25-02796"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y.-J.S.</given-names></name><name><surname>Higgs</surname><given-names>S.</given-names></name><name><surname>Vanlandingham</surname><given-names>D.L.</given-names></name></person-group><article-title>Emergence and re-emergence of mosquito-borne arboviruses</article-title><source>Curr. Opin. Virol.</source><year>2019</year><volume>34</volume><fpage>104</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.coviro.2019.01.001</pub-id><?supplied-pmid 30743191?><pub-id pub-id-type="pmid">30743191</pub-id></element-citation></ref><ref id="B13-molecules-25-02796"><label>13.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Halstead</surname><given-names>S.B.</given-names></name></person-group><article-title>Chapter 3-Chikungunya and Zika Disease</article-title><source>Chikungunya and Zika Viruses</source><person-group person-group-type="editor"><name><surname>Higgs</surname><given-names>S.</given-names></name><name><surname>Vanlandingham</surname><given-names>D.L.</given-names></name><name><surname>Powers</surname><given-names>A.M.</given-names></name></person-group><publisher-name>Academic Press</publisher-name><publisher-loc>London, UK</publisher-loc><year>2018</year><fpage>69</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-811865-8.00003-9</pub-id></element-citation></ref><ref id="B14-molecules-25-02796"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao-Lormeau</surname><given-names>V.-M.</given-names></name><name><surname>Blake</surname><given-names>A.</given-names></name><name><surname>Mons</surname><given-names>S.</given-names></name><name><surname>Last&#x000e8;re</surname><given-names>S.</given-names></name><name><surname>Roche</surname><given-names>C.</given-names></name><name><surname>Vanhomwegen</surname><given-names>J.</given-names></name><name><surname>Dub</surname><given-names>T.</given-names></name><name><surname>Baudouin</surname><given-names>L.</given-names></name><name><surname>Teissier</surname><given-names>A.</given-names></name><name><surname>Larre</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Guillain-Barr&#x000e9; Syndrome outbreak associated with Zika virus infection in French Polynesia: A case-control study</article-title><source>Lancet</source><year>2016</year><volume>387</volume><fpage>1531</fpage><lpage>1539</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(16)00562-6</pub-id><pub-id pub-id-type="pmid">26948433</pub-id></element-citation></ref><ref id="B15-molecules-25-02796"><label>15.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>Sanofi Pasteur</collab></person-group><article-title>Press Release: Dengvaxia<sup>&#x000ae;</sup>, World&#x02019;s First Dengue Vaccine, Approved in Mexico</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.sanofi.com/en/media-room/press-releases/2015/2015-12-09-16-30-00">https://www.sanofi.com/en/media-room/press-releases/2015/2015-12-09-16-30-00</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-04-09">(accessed on 9 April 2020)</date-in-citation></element-citation></ref><ref id="B16-molecules-25-02796"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><article-title>Japanese Encephalitis Vaccines: WHO position paper&#x02013;February 2015</article-title><source>Wkly Epidemiol. Rec.</source><year>2015</year><volume>90</volume><fpage>69</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">25726573</pub-id></element-citation></ref><ref id="B17-molecules-25-02796"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>T.</given-names></name><name><surname>Hathaway</surname><given-names>D.</given-names></name><name><surname>Jennings</surname><given-names>N.</given-names></name><name><surname>Champ</surname><given-names>D.</given-names></name><name><surname>Chiang</surname><given-names>Y.W.</given-names></name><name><surname>Chu</surname><given-names>H.J.</given-names></name></person-group><article-title>Equine vaccine for West Nile virus</article-title><source>Dev. Biol.</source><year>2003</year><volume>114</volume><fpage>221</fpage><lpage>227</lpage></element-citation></ref><ref id="B18-molecules-25-02796"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>M.T.</given-names></name><name><surname>Gibbs</surname><given-names>E.P.J.</given-names></name><name><surname>Mellencamp</surname><given-names>M.W.</given-names></name><name><surname>Bowen</surname><given-names>R.A.</given-names></name><name><surname>Seino</surname><given-names>K.K.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Beachboard</surname><given-names>S.E.</given-names></name><name><surname>Humphrey</surname><given-names>P.P.</given-names></name></person-group><article-title>Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model</article-title><source>Equine Vet. J.</source><year>2007</year><volume>39</volume><fpage>491</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.2746/042516407X217416</pub-id><pub-id pub-id-type="pmid">18065305</pub-id></element-citation></ref><ref id="B19-molecules-25-02796"><label>19.</label><element-citation publication-type="gov"><person-group person-group-type="author"><collab>U.S. Food and Drug Administration</collab></person-group><article-title>Vaccines Licensed for Use in the United States</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states">https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-04-01">(accessed on 1 April 2020)</date-in-citation></element-citation></ref><ref id="B20-molecules-25-02796"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Pandey</surname><given-names>A.K.</given-names></name></person-group><article-title>Chemistry and Biological Activities of Flavonoids: An Overview</article-title><source>Sci. World J.</source><year>2013</year><volume>2013</volume><fpage>162750</fpage><pub-id pub-id-type="doi">10.1155/2013/162750</pub-id><?supplied-pmid 24470791?><pub-id pub-id-type="pmid">24470791</pub-id></element-citation></ref><ref id="B21-molecules-25-02796"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suroowan</surname><given-names>S.</given-names></name><name><surname>Mahomoodally</surname><given-names>F.</given-names></name><name><surname>Ragoo</surname><given-names>L.</given-names></name></person-group><article-title>Management and Treatment of Dengue and Chikungunya-Natural Products to the Rescue</article-title><source>Comb. Chem. High Throughput Screen.</source><year>2016</year><volume>19</volume><fpage>554</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.2174/1386207319666160506123401</pub-id><?supplied-pmid 27151484?><pub-id pub-id-type="pmid">27151484</pub-id></element-citation></ref><ref id="B22-molecules-25-02796"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>A.K.</given-names></name><name><surname>Munoz</surname><given-names>A.L.</given-names></name><name><surname>Segura</surname><given-names>N.A.</given-names></name><name><surname>Rangel</surname><given-names>H.R.</given-names></name><name><surname>Bello</surname><given-names>F.</given-names></name></person-group><article-title>Molecular characteristics and replication mechanism of dengue, zika and chikungunya arboviruses, and their treatments with natural extracts from plants: An updated review</article-title><source>EXCLI J.</source><year>2019</year><volume>18</volume><fpage>988</fpage><lpage>1006</lpage><pub-id pub-id-type="doi">10.17179/excli2019-1825</pub-id><?supplied-pmid 31762724?><pub-id pub-id-type="pmid">31762724</pub-id></element-citation></ref><ref id="B23-molecules-25-02796"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>A.F.</given-names></name><name><surname>Teixeira</surname><given-names>R.R.</given-names></name><name><surname>Oliveira</surname><given-names>A.S.</given-names></name><name><surname>Souza</surname><given-names>A.P.</given-names></name><name><surname>Silva</surname><given-names>M.L.</given-names></name><name><surname>Paula</surname><given-names>S.O.</given-names></name></person-group><article-title>Potential Antivirals: Natural Products Targeting Replication Enzymes of Dengue and Chikungunya Viruses</article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>505</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22030505</pub-id></element-citation></ref><ref id="B24-molecules-25-02796"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brady</surname><given-names>O.J.</given-names></name><name><surname>Gething</surname><given-names>P.W.</given-names></name><name><surname>Bhatt</surname><given-names>S.</given-names></name><name><surname>Messina</surname><given-names>J.P.</given-names></name><name><surname>Brownstein</surname><given-names>J.S.</given-names></name><name><surname>Hoen</surname><given-names>A.G.</given-names></name><name><surname>Moyes</surname><given-names>C.L.</given-names></name><name><surname>Farlow</surname><given-names>A.W.</given-names></name><name><surname>Scott</surname><given-names>T.W.</given-names></name><name><surname>Hay</surname><given-names>S.I.</given-names></name></person-group><article-title>Refining the global spatial limits of dengue virus transmission by evidence-based consensus</article-title><source>PLoS Negl. Trop. Dis.</source><year>2012</year><volume>6</volume><elocation-id>e1760</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0001760</pub-id><pub-id pub-id-type="pmid">22880140</pub-id></element-citation></ref><ref id="B25-molecules-25-02796"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatt</surname><given-names>S.</given-names></name><name><surname>Gething</surname><given-names>P.W.</given-names></name><name><surname>Brady</surname><given-names>O.J.</given-names></name><name><surname>Messina</surname><given-names>J.P.</given-names></name><name><surname>Farlow</surname><given-names>A.W.</given-names></name><name><surname>Moyes</surname><given-names>C.L.</given-names></name><name><surname>Drake</surname><given-names>J.M.</given-names></name><name><surname>Brownstein</surname><given-names>J.S.</given-names></name><name><surname>Hoen</surname><given-names>A.G.</given-names></name><name><surname>Sankoh</surname><given-names>O.</given-names></name><etal/></person-group><article-title>The global distribution and burden of dengue</article-title><source>Nature</source><year>2013</year><volume>496</volume><fpage>504</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1038/nature12060</pub-id><pub-id pub-id-type="pmid">23563266</pub-id></element-citation></ref><ref id="B26-molecules-25-02796"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waggoner</surname><given-names>J.J.</given-names></name><name><surname>Gresh</surname><given-names>L.</given-names></name><name><surname>Vargas</surname><given-names>M.J.</given-names></name><name><surname>Ballesteros</surname><given-names>G.</given-names></name><name><surname>Tellez</surname><given-names>Y.</given-names></name><name><surname>Soda</surname><given-names>K.J.</given-names></name><name><surname>Sahoo</surname><given-names>M.K.</given-names></name><name><surname>Nu&#x000f1;ez</surname><given-names>A.</given-names></name><name><surname>Balmaseda</surname><given-names>A.</given-names></name><name><surname>Harris</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Viremia and Clinical Presentation in Nicaraguan Patients Infected With Zika Virus, Chikungunya Virus, and Dengue Virus</article-title><source>Clin. Infect. Dis.</source><year>2016</year><volume>63</volume><fpage>1584</fpage><lpage>1590</lpage><pub-id pub-id-type="doi">10.1093/cid/ciw589</pub-id><pub-id pub-id-type="pmid">27578819</pub-id></element-citation></ref><ref id="B27-molecules-25-02796"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sridhar</surname><given-names>S.</given-names></name><name><surname>Luedtke</surname><given-names>A.</given-names></name><name><surname>Langevin</surname><given-names>E.</given-names></name><name><surname>Zhu</surname><given-names>M.</given-names></name><name><surname>Bonaparte</surname><given-names>M.</given-names></name><name><surname>Machabert</surname><given-names>T.</given-names></name><name><surname>Savarino</surname><given-names>S.</given-names></name><name><surname>Zambrano</surname><given-names>B.</given-names></name><name><surname>Moureau</surname><given-names>A.</given-names></name><name><surname>Khromava</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy</article-title><source>N. Engl. J. Med.</source><year>2018</year><volume>379</volume><fpage>327</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1800820</pub-id><pub-id pub-id-type="pmid">29897841</pub-id></element-citation></ref><ref id="B28-molecules-25-02796"><label>28.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>Sanofi Pasteur</collab></person-group><article-title>Press Release: Sanofi Updates Information on Dengue Vaccine</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.sanofi.com/en/media-room/press-releases/2017/2017-11-29-17-36-30">https://www.sanofi.com/en/media-room/press-releases/2017/2017-11-29-17-36-30</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-04-09">(accessed on 9 April 2020)</date-in-citation></element-citation></ref><ref id="B29-molecules-25-02796"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadinegoro</surname><given-names>S.R.</given-names></name><name><surname>Arredondo-Garc&#x000ed;a</surname><given-names>J.L.</given-names></name><name><surname>Capeding</surname><given-names>M.R.</given-names></name><name><surname>Deseda</surname><given-names>C.</given-names></name><name><surname>Chotpitayasunondh</surname><given-names>T.</given-names></name><name><surname>Dietze</surname><given-names>R.</given-names></name><name><surname>Hj Muhammad Ismail</surname><given-names>H.I.</given-names></name><name><surname>Reynales</surname><given-names>H.</given-names></name><name><surname>Limkittikul</surname><given-names>K.</given-names></name><name><surname>Rivera-Medina</surname><given-names>D.M.</given-names></name><etal/></person-group><article-title>Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease</article-title><source>N. Engl. J. Med.</source><year>2015</year><volume>373</volume><fpage>1195</fpage><lpage>1206</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1506223</pub-id><pub-id pub-id-type="pmid">26214039</pub-id></element-citation></ref><ref id="B30-molecules-25-02796"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>G.</given-names></name><name><surname>Hills</surname><given-names>S.</given-names></name><name><surname>Fischer</surname><given-names>M.</given-names></name><name><surname>Jacobson</surname><given-names>J.</given-names></name><name><surname>Hoke</surname><given-names>C.</given-names></name><name><surname>Hombach</surname><given-names>J.</given-names></name><name><surname>Marfin</surname><given-names>A.</given-names></name><name><surname>Solomon</surname><given-names>T.</given-names></name><name><surname>Tsai</surname><given-names>T.</given-names></name><name><surname>Tsui</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Estimated global incidence of Japanese encephalitis</article-title><source>Bull. World Health Organ.</source><year>2011</year><volume>89</volume><fpage>766</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.2471/BLT.10.085233</pub-id><?supplied-pmid 22084515?><pub-id pub-id-type="pmid">22084515</pub-id></element-citation></ref><ref id="B31-molecules-25-02796"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erlanger</surname><given-names>T.E.</given-names></name><name><surname>Weiss</surname><given-names>S.</given-names></name><name><surname>Keiser</surname><given-names>J.</given-names></name><name><surname>Utzinger</surname><given-names>J.</given-names></name><name><surname>Wiedenmayer</surname><given-names>K.</given-names></name></person-group><article-title>Past, Present, and Future of Japanese Encephalitis</article-title><source>Emerg. Infect. Dis.</source><year>2009</year><volume>15</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.3201/eid1501.080311</pub-id><?supplied-pmid 19116041?><pub-id pub-id-type="pmid">19116041</pub-id></element-citation></ref><ref id="B32-molecules-25-02796"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>N.J.C.</given-names></name><name><surname>Getts</surname><given-names>D.R.</given-names></name><name><surname>Getts</surname><given-names>M.T.</given-names></name><name><surname>Rana</surname><given-names>S.</given-names></name><name><surname>Shrestha</surname><given-names>B.</given-names></name><name><surname>Kesson</surname><given-names>A.M.</given-names></name></person-group><article-title>Immunopathology of flavivirus infections</article-title><source>Immunol. Cell Biol.</source><year>2007</year><volume>85</volume><fpage>33</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1038/sj.icb.7100012</pub-id><?supplied-pmid 17146465?><pub-id pub-id-type="pmid">17146465</pub-id></element-citation></ref><ref id="B33-molecules-25-02796"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solomon</surname><given-names>T.</given-names></name></person-group><article-title>Japanese encephalitis</article-title><source>J. Neurol. Neurosurg. Psychiatry</source><year>2000</year><volume>68</volume><fpage>405</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1136/jnnp.68.4.405</pub-id><?supplied-pmid 10727474?><pub-id pub-id-type="pmid">10727474</pub-id></element-citation></ref><ref id="B34-molecules-25-02796"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Gessel</surname><given-names>Y.</given-names></name><name><surname>Klade</surname><given-names>C.S.</given-names></name><name><surname>Putnak</surname><given-names>R.</given-names></name><name><surname>Formica</surname><given-names>A.</given-names></name><name><surname>Krasaesub</surname><given-names>S.</given-names></name><name><surname>Spruth</surname><given-names>M.</given-names></name><name><surname>Cena</surname><given-names>B.</given-names></name><name><surname>Tungtaeng</surname><given-names>A.</given-names></name><name><surname>Gettayacamin</surname><given-names>M.</given-names></name><name><surname>Dewasthaly</surname><given-names>S.</given-names></name></person-group><article-title>Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO<sup>&#x000ae;</sup>) induced neutralizing antibody titers</article-title><source>Vaccine</source><year>2011</year><volume>29</volume><fpage>5925</fpage><lpage>5931</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2011.06.062</pub-id><pub-id pub-id-type="pmid">21723353</pub-id></element-citation></ref><ref id="B35-molecules-25-02796"><label>35.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><article-title>Fact Sheet: Japanese Encephalitis</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/en/news-room/fact-sheets/detail/japanese-encephalitis">https://www.who.int/en/news-room/fact-sheets/detail/japanese-encephalitis</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-04-07">(accessed on 7 April 2020)</date-in-citation></element-citation></ref><ref id="B36-molecules-25-02796"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yun</surname><given-names>S.-I.</given-names></name><name><surname>Lee</surname><given-names>Y.-M.</given-names></name></person-group><article-title>Japanese encephalitis</article-title><source>Hum. Vaccines Immunother.</source><year>2014</year><volume>10</volume><fpage>263</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.4161/hv.26902</pub-id></element-citation></ref><ref id="B37-molecules-25-02796"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nash</surname><given-names>D.</given-names></name><name><surname>Mostashari</surname><given-names>F.</given-names></name><name><surname>Fine</surname><given-names>A.</given-names></name><name><surname>Miller</surname><given-names>J.</given-names></name><name><surname>O&#x02019;Leary</surname><given-names>D.</given-names></name><name><surname>Murray</surname><given-names>K.</given-names></name><name><surname>Huang</surname><given-names>A.</given-names></name><name><surname>Rosenberg</surname><given-names>A.</given-names></name><name><surname>Greenberg</surname><given-names>A.</given-names></name><name><surname>Sherman</surname><given-names>M.</given-names></name><etal/></person-group><article-title>The Outbreak of West Nile Virus Infection in the New York City Area in 1999</article-title><source>N. Engl. J. Med.</source><year>2001</year><volume>344</volume><fpage>1807</fpage><lpage>1814</lpage><pub-id pub-id-type="doi">10.1056/NEJM200106143442401</pub-id><pub-id pub-id-type="pmid">11407341</pub-id></element-citation></ref><ref id="B38-molecules-25-02796"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer</surname><given-names>L.D.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>P.-Y.</given-names></name></person-group><article-title>West Nile virus</article-title><source>Lancet Neurol.</source><year>2007</year><volume>6</volume><fpage>171</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(07)70030-3</pub-id><pub-id pub-id-type="pmid">17239804</pub-id></element-citation></ref><ref id="B39-molecules-25-02796"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasci</surname><given-names>R.S.</given-names></name><name><surname>Savage</surname><given-names>H.M.</given-names></name><name><surname>White</surname><given-names>D.J.</given-names></name><name><surname>Miller</surname><given-names>J.R.</given-names></name><name><surname>Cropp</surname><given-names>B.C.</given-names></name><name><surname>Godsey</surname><given-names>M.S.</given-names></name><name><surname>Kerst</surname><given-names>A.J.</given-names></name><name><surname>Bennett</surname><given-names>P.</given-names></name><name><surname>Gottfried</surname><given-names>K.</given-names></name><name><surname>Lanciotti</surname><given-names>R.S.</given-names></name></person-group><article-title>West Nile Virus in Overwintering Culex Mosquitoes, New York City, 2000</article-title><source>Emerg. Infect. Dis.</source><year>2001</year><volume>7</volume><fpage>742</fpage><lpage>744</lpage><pub-id pub-id-type="doi">10.3201/eid0704.017426</pub-id><pub-id pub-id-type="pmid">11585542</pub-id></element-citation></ref><ref id="B40-molecules-25-02796"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>E.B.</given-names></name><name><surname>Sejvar</surname><given-names>J.J.</given-names></name><name><surname>Zaki</surname><given-names>S.R.</given-names></name><name><surname>Lanciotti</surname><given-names>R.S.</given-names></name><name><surname>Bode</surname><given-names>A.V.</given-names></name><name><surname>Campbell</surname><given-names>G.L.</given-names></name></person-group><article-title>Virology, pathology, and clinical manifestations of West Nile virus disease</article-title><source>Emerg. Infect. Dis.</source><year>2005</year><volume>11</volume><fpage>1174</fpage><lpage>1179</lpage><pub-id pub-id-type="doi">10.3201/eid1108.050289b</pub-id><pub-id pub-id-type="pmid">16102303</pub-id></element-citation></ref><ref id="B41-molecules-25-02796"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mostashari</surname><given-names>F.</given-names></name><name><surname>Bunning</surname><given-names>M.L.</given-names></name><name><surname>Kitsutani</surname><given-names>P.T.</given-names></name><name><surname>Singer</surname><given-names>D.A.</given-names></name><name><surname>Nash</surname><given-names>D.</given-names></name><name><surname>Cooper</surname><given-names>M.J.</given-names></name><name><surname>Katz</surname><given-names>N.</given-names></name><name><surname>Liljebjelke</surname><given-names>K.A.</given-names></name><name><surname>Biggerstaff</surname><given-names>B.J.</given-names></name><name><surname>Fine</surname><given-names>A.D.</given-names></name><etal/></person-group><article-title>Epidemic West Nile encephalitis, New York, 1999: Results of a household-based seroepidemiological survey</article-title><source>Lancet</source><year>2001</year><volume>358</volume><fpage>261</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(01)05480-0</pub-id><pub-id pub-id-type="pmid">11498211</pub-id></element-citation></ref><ref id="B42-molecules-25-02796"><label>42.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><article-title>Fact Sheet: West Nile Virus</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/west-nile-virus">https://www.who.int/news-room/fact-sheets/detail/west-nile-virus</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-04-06">(accessed on 6 April 2020)</date-in-citation></element-citation></ref><ref id="B43-molecules-25-02796"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>K.O.</given-names></name><name><surname>Walker</surname><given-names>C.</given-names></name><name><surname>Gould</surname><given-names>E.</given-names></name></person-group><article-title>The virology, epidemiology, and clinical impact of West Nile virus: A decade of advancements in research since its introduction into the Western Hemisphere</article-title><source>Epidemiol. Infect.</source><year>2011</year><volume>139</volume><fpage>807</fpage><lpage>817</lpage><pub-id pub-id-type="doi">10.1017/S0950268811000185</pub-id><?supplied-pmid 21342610?><pub-id pub-id-type="pmid">21342610</pub-id></element-citation></ref><ref id="B44-molecules-25-02796"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sejvar</surname><given-names>J.J.</given-names></name></person-group><article-title>The Long-Term Outcomes of Human West Nile Virus Infection</article-title><source>Clin. Infect. Dis.</source><year>2007</year><volume>44</volume><fpage>1617</fpage><lpage>1624</lpage><pub-id pub-id-type="doi">10.1086/518281</pub-id><?supplied-pmid 17516407?><pub-id pub-id-type="pmid">17516407</pub-id></element-citation></ref><ref id="B45-molecules-25-02796"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacenti</surname><given-names>M.</given-names></name><name><surname>Sinigaglia</surname><given-names>A.</given-names></name><name><surname>Franchin</surname><given-names>E.</given-names></name><name><surname>Pagni</surname><given-names>S.</given-names></name><name><surname>Lavezzo</surname><given-names>E.</given-names></name><name><surname>Montarsi</surname><given-names>F.</given-names></name><name><surname>Capelli</surname><given-names>G.</given-names></name><name><surname>Barzon</surname><given-names>L.</given-names></name></person-group><article-title>Human West Nile Virus Lineage 2 Infection: Epidemiological, Clinical, and Virological Findings</article-title><source>Viruses</source><year>2020</year><volume>12</volume><elocation-id>458</elocation-id><pub-id pub-id-type="doi">10.3390/v12040458</pub-id><?supplied-pmid 32325716?><pub-id pub-id-type="pmid">32325716</pub-id></element-citation></ref><ref id="B46-molecules-25-02796"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dick</surname><given-names>G.W.A.</given-names></name><name><surname>Kitchen</surname><given-names>S.F.</given-names></name><name><surname>Haddow</surname><given-names>A.J.</given-names></name></person-group><article-title>Zika Virus (I). Isolations and serological specificity</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>1952</year><volume>46</volume><fpage>509</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(52)90042-4</pub-id><pub-id pub-id-type="pmid">12995440</pub-id></element-citation></ref><ref id="B47-molecules-25-02796"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duffy</surname><given-names>M.R.</given-names></name><name><surname>Chen</surname><given-names>T.-H.</given-names></name><name><surname>Hancock</surname><given-names>W.T.</given-names></name><name><surname>Powers</surname><given-names>A.M.</given-names></name><name><surname>Kool</surname><given-names>J.L.</given-names></name><name><surname>Lanciotti</surname><given-names>R.S.</given-names></name><name><surname>Pretrick</surname><given-names>M.</given-names></name><name><surname>Marfel</surname><given-names>M.</given-names></name><name><surname>Holzbauer</surname><given-names>S.</given-names></name><name><surname>Dubray</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Zika Virus Outbreak on Yap Island, Federated States of Micronesia</article-title><source>N. Engl. J. Med.</source><year>2009</year><volume>360</volume><fpage>2536</fpage><lpage>2543</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0805715</pub-id><?supplied-pmid 19516034?><pub-id pub-id-type="pmid">19516034</pub-id></element-citation></ref><ref id="B48-molecules-25-02796"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao-Lormeau</surname><given-names>V.-M.</given-names></name><name><surname>Roche</surname><given-names>C.</given-names></name><name><surname>Teissier</surname><given-names>A.</given-names></name><name><surname>Robin</surname><given-names>E.</given-names></name><name><surname>Berry</surname><given-names>A.-L.</given-names></name><name><surname>Mallet</surname><given-names>H.-P.</given-names></name><name><surname>Sall</surname><given-names>A.A.</given-names></name><name><surname>Musso</surname><given-names>D.</given-names></name></person-group><article-title>Zika Virus, French Polynesia, South Pacific, 2013</article-title><source>Emerg. Infect. Dis.</source><year>2014</year><volume>20</volume><fpage>1084</fpage><lpage>1086</lpage><pub-id pub-id-type="doi">10.3201/eid2006.140138</pub-id><?supplied-pmid 24856001?><pub-id pub-id-type="pmid">24856001</pub-id></element-citation></ref><ref id="B49-molecules-25-02796"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dupont-Rouzeyrol</surname><given-names>M.</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>O.</given-names></name><name><surname>Calvez</surname><given-names>E.</given-names></name><name><surname>Daur&#x000e8;s</surname><given-names>M.</given-names></name><name><surname>John</surname><given-names>M.</given-names></name><name><surname>Grangeon</surname><given-names>J.-P.</given-names></name><name><surname>Gourinat</surname><given-names>A.-C.</given-names></name></person-group><article-title>Co-infection with Zika and Dengue Viruses in 2 Patients, New Caledonia, 2014</article-title><source>Emerg. Infect. Dis.</source><year>2015</year><volume>21</volume><fpage>381</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.3201/eid2102.141553</pub-id><pub-id pub-id-type="pmid">25625687</pub-id></element-citation></ref><ref id="B50-molecules-25-02796"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musso</surname><given-names>D.</given-names></name></person-group><article-title>Zika Virus Transmission from French Polynesia to Brazil</article-title><source>Emerg. Infect. Dis.</source><year>2015</year><volume>21</volume><fpage>1887</fpage><pub-id pub-id-type="doi">10.3201/eid2110.151125</pub-id></element-citation></ref><ref id="B51-molecules-25-02796"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campos</surname><given-names>G.S.</given-names></name><name><surname>Bandeira</surname><given-names>A.C.</given-names></name><name><surname>Sardi</surname><given-names>S.I.</given-names></name></person-group><article-title>Zika Virus Outbreak, Bahia, Brazil</article-title><source>Emerg. Infect. Dis.</source><year>2015</year><volume>21</volume><fpage>1885</fpage><lpage>1886</lpage><pub-id pub-id-type="doi">10.3201/eid2110.150847</pub-id><pub-id pub-id-type="pmid">26401719</pub-id></element-citation></ref><ref id="B52-molecules-25-02796"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mlakar</surname><given-names>J.</given-names></name><name><surname>Korva</surname><given-names>M.</given-names></name><name><surname>Tul</surname><given-names>N.</given-names></name><name><surname>Popovi&#x00107;</surname><given-names>M.</given-names></name><name><surname>Polj&#x00161;ak-Prijatelj</surname><given-names>M.</given-names></name><name><surname>Mraz</surname><given-names>J.</given-names></name><name><surname>Kolenc</surname><given-names>M.</given-names></name><name><surname>Resman Rus</surname><given-names>K.</given-names></name><name><surname>Vesnaver Vipotnik</surname><given-names>T.</given-names></name><name><surname>Fabjan Vodu&#x00161;ek</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Zika Virus Associated with Microcephaly</article-title><source>N. Engl. J. Med.</source><year>2016</year><volume>374</volume><fpage>951</fpage><lpage>958</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1600651</pub-id><pub-id pub-id-type="pmid">26862926</pub-id></element-citation></ref><ref id="B53-molecules-25-02796"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuler-Faccini</surname><given-names>L.</given-names></name><name><surname>Ribeiro</surname><given-names>E.M.</given-names></name><name><surname>Feitosa</surname><given-names>I.M.L.</given-names></name><name><surname>Horovitz</surname><given-names>D.D.G.</given-names></name><name><surname>Cavalcanti</surname><given-names>D.P.</given-names></name><name><surname>Pessoa</surname><given-names>A.</given-names></name><name><surname>DoriquI</surname><given-names>M.J.R.</given-names></name><name><surname>Neri</surname><given-names>J.I.</given-names></name><name><surname>de Pina Neto</surname><given-names>J.M.</given-names></name><name><surname>Wanderley</surname><given-names>H.Y.C.</given-names></name><etal/></person-group><article-title>Possible Association Between Zika Virus Infection and Microcephaly&#x02014;Brazil, 2015</article-title><source>Morb. Mortal. Wkly Rep.</source><year>2016</year><volume>65</volume><fpage>59</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm6503e2</pub-id><?supplied-pmid 26820244?><pub-id pub-id-type="pmid">26820244</pub-id></element-citation></ref><ref id="B54-molecules-25-02796"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000e9;charles</surname><given-names>S.M.D.</given-names></name><name><surname>Herrmann</surname><given-names>C.M.D.</given-names></name><name><surname>Poullain</surname><given-names>P.M.D.</given-names></name><name><surname>Tran</surname><given-names>T.-H.M.B.</given-names></name><name><surname>Deschamps</surname><given-names>N.M.B.</given-names></name><name><surname>Mathon</surname><given-names>G.M.D.</given-names></name><name><surname>Landais</surname><given-names>A.M.D.</given-names></name><name><surname>Breurec</surname><given-names>S.M.D.</given-names></name><name><surname>Lannuzel</surname><given-names>A.P.</given-names></name></person-group><article-title>Acute myelitis due to Zika virus infection</article-title><source>Lancet</source><year>2016</year><volume>387</volume><fpage>1481</fpage><pub-id pub-id-type="doi">10.1016/S0140-6736(16)00644-9</pub-id><pub-id pub-id-type="pmid">26946926</pub-id></element-citation></ref><ref id="B55-molecules-25-02796"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carteaux</surname><given-names>G.</given-names></name><name><surname>Maquart</surname><given-names>M.</given-names></name><name><surname>Bedet</surname><given-names>A.</given-names></name><name><surname>Contou</surname><given-names>D.</given-names></name><name><surname>Brugi&#x000e8;res</surname><given-names>P.</given-names></name><name><surname>Fourati</surname><given-names>S.</given-names></name><name><surname>de Langavant</surname><given-names>L.C.</given-names></name><name><surname>de Broucker</surname><given-names>T.</given-names></name><name><surname>Brun-Buisson</surname><given-names>C.</given-names></name><name><surname>Leparc-Goffart</surname><given-names>I.</given-names></name><etal/></person-group><article-title>Zika Virus Associated with Meningoencephalitis</article-title><source>N. Engl. J. Med.</source><year>2016</year><volume>374</volume><fpage>1595</fpage><lpage>1596</lpage><pub-id pub-id-type="doi">10.1056/NEJMc1602964</pub-id><?supplied-pmid 26958738?><pub-id pub-id-type="pmid">26958738</pub-id></element-citation></ref><ref id="B56-molecules-25-02796"><label>56.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Powers</surname><given-names>A.M.</given-names></name></person-group><article-title>Chapter 1-The Origins of Chikungunya and Zika Viruses-History of the Discoveries</article-title><source>Chikungunya and Zika Viruses</source><person-group person-group-type="editor"><name><surname>Higgs</surname><given-names>S.</given-names></name><name><surname>Vanlandingham</surname><given-names>D.L.</given-names></name><name><surname>Powers</surname><given-names>A.M.</given-names></name></person-group><publisher-name>Academic Press</publisher-name><publisher-loc>London, UK</publisher-loc><year>2018</year><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/b978-0-12-811865-8.00001-5</pub-id></element-citation></ref><ref id="B57-molecules-25-02796"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>M.C.</given-names></name></person-group><article-title>An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952&#x02013;1953</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>1955</year><volume>49</volume><fpage>28</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(55)90080-8</pub-id><pub-id pub-id-type="pmid">14373834</pub-id></element-citation></ref><ref id="B58-molecules-25-02796"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caglioti</surname><given-names>C.</given-names></name><name><surname>Lalle</surname><given-names>E.</given-names></name><name><surname>Castilletti</surname><given-names>C.</given-names></name><name><surname>Carletti</surname><given-names>F.</given-names></name><name><surname>Capobianchi</surname><given-names>M.R.</given-names></name><name><surname>Bordi</surname><given-names>L.</given-names></name></person-group><article-title>Chikungunya virus infection: An overview</article-title><source>New Microbiol.</source><year>2013</year><volume>36</volume><fpage>211</fpage><pub-id pub-id-type="pmid">23912863</pub-id></element-citation></ref><ref id="B59-molecules-25-02796"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammon</surname><given-names>W.M.</given-names></name><name><surname>Rudnick</surname><given-names>A.</given-names></name><name><surname>Sather</surname><given-names>G.E.</given-names></name></person-group><article-title>Viruses Associated with Epidemic Hemorrhagic Fevers of the Philippines and Thailand</article-title><source>Science</source><year>1960</year><volume>131</volume><fpage>1102</fpage><lpage>1103</lpage><pub-id pub-id-type="doi">10.1126/science.131.3407.1102</pub-id><pub-id pub-id-type="pmid">14399343</pub-id></element-citation></ref><ref id="B60-molecules-25-02796"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>S.C.</given-names></name></person-group><article-title>Arrival of Chikungunya Virus in the New World: Prospects for Spread and Impact on Public Health</article-title><source>PLoS Negl. Trop. Dis.</source><year>2014</year><volume>8</volume><elocation-id>e2921</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0002921</pub-id><pub-id pub-id-type="pmid">24967777</pub-id></element-citation></ref><ref id="B61-molecules-25-02796"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sourisseau</surname><given-names>M.</given-names></name><name><surname>Schilte</surname><given-names>C.</given-names></name><name><surname>Casartelli</surname><given-names>N.</given-names></name><name><surname>Trouillet</surname><given-names>C.</given-names></name><name><surname>Guivel-Benhassine</surname><given-names>F.</given-names></name><name><surname>Rudnicka</surname><given-names>D.</given-names></name><name><surname>Sol-Foulon</surname><given-names>N.</given-names></name><name><surname>Roux</surname><given-names>K.L.</given-names></name><name><surname>Prevost</surname><given-names>M.-C.</given-names></name><name><surname>Fsihi</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Characterization of Reemerging Chikungunya Virus</article-title><source>PLoS Pathog.</source><year>2007</year><volume>3</volume><elocation-id>e89</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.0030089</pub-id><pub-id pub-id-type="pmid">17604450</pub-id></element-citation></ref><ref id="B62-molecules-25-02796"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuffenecker</surname><given-names>I.</given-names></name><name><surname>Iteman</surname><given-names>I.</given-names></name><name><surname>Michault</surname><given-names>A.</given-names></name><name><surname>Murri</surname><given-names>S.</given-names></name><name><surname>Frangeul</surname><given-names>L.</given-names></name><name><surname>Vaney</surname><given-names>M.-C.</given-names></name><name><surname>Lavenir</surname><given-names>R.</given-names></name><name><surname>Pardigon</surname><given-names>N.</given-names></name><name><surname>Reynes</surname><given-names>J.-M.</given-names></name><name><surname>Pettinelli</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Genome Microevolution of Chikungunya Viruses Causing the Indian Ocean Outbreak</article-title><source>PLoS Med.</source><year>2006</year><volume>3</volume><elocation-id>e263</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.0030263</pub-id><pub-id pub-id-type="pmid">16700631</pub-id></element-citation></ref><ref id="B63-molecules-25-02796"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enserink</surname><given-names>M.</given-names></name></person-group><article-title>Massive Outbreak Draws Fresh Attention to Little-Known Virus</article-title><source>Science</source><year>2006</year><volume>311</volume><fpage>1085a</fpage><pub-id pub-id-type="doi">10.1126/science.311.5764.1085a</pub-id><pub-id pub-id-type="pmid">16497896</pub-id></element-citation></ref><ref id="B64-molecules-25-02796"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>J.</given-names></name><name><surname>Sammon</surname><given-names>M.</given-names></name><name><surname>Garg</surname><given-names>M.</given-names></name></person-group><article-title>Dengue, Zika and Chikungunya: Emerging Arboviruses in the New World</article-title><source>West. J. Emerg. Med.</source><year>2016</year><volume>17</volume><fpage>671</fpage><lpage>679</lpage><pub-id pub-id-type="doi">10.5811/westjem.2016.9.30904</pub-id><?supplied-pmid 27833670?><pub-id pub-id-type="pmid">27833670</pub-id></element-citation></ref><ref id="B65-molecules-25-02796"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>K.Z.</given-names></name><name><surname>Chu</surname><given-names>J.J.H.</given-names></name></person-group><article-title>The Interplay of Viral and Host Factors in Chikungunya Virus Infection: Targets for Antiviral Strategies</article-title><source>Viruses</source><year>2018</year><volume>10</volume><elocation-id>294</elocation-id><pub-id pub-id-type="doi">10.3390/v10060294</pub-id><?supplied-pmid 29849008?><pub-id pub-id-type="pmid">29849008</pub-id></element-citation></ref><ref id="B66-molecules-25-02796"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>P.L.</given-names></name><name><surname>Oh</surname><given-names>H.M.L.</given-names></name><name><surname>Ooi</surname><given-names>E.E.</given-names></name></person-group><article-title>Chikungunya in Singapore: Imported Cases Among Travelers Visiting Friends and Relatives</article-title><source>J. Travel Med.</source><year>2009</year><volume>16</volume><fpage>289</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1111/j.1708-8305.2009.00313.x</pub-id><?supplied-pmid 19674272?><pub-id pub-id-type="pmid">19674272</pub-id></element-citation></ref><ref id="B67-molecules-25-02796"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hapuarachchi</surname><given-names>H.C.</given-names></name><name><surname>Bandara</surname><given-names>K.B.A.T.</given-names></name><name><surname>Sumanadasa</surname><given-names>S.D.M.</given-names></name><name><surname>Hapugoda</surname><given-names>M.D.</given-names></name><name><surname>Lai</surname><given-names>Y.L.</given-names></name><name><surname>Lee</surname><given-names>K.S.</given-names></name><name><surname>Tan</surname><given-names>L.K.</given-names></name><name><surname>Lin</surname><given-names>R.T.P.</given-names></name><name><surname>Ng</surname><given-names>L.F.P.</given-names></name><name><surname>Bucht</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Re-emergence of Chikungunya virus in South-east Asia: Virological evidence from Sri Lanka and Singapore</article-title><source>J. Gen. Virol.</source><year>2010</year><volume>91</volume><fpage>1067</fpage><lpage>1076</lpage><pub-id pub-id-type="doi">10.1099/vir.0.015743-0</pub-id><?supplied-pmid 19955565?><pub-id pub-id-type="pmid">19955565</pub-id></element-citation></ref><ref id="B68-molecules-25-02796"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochedez</surname><given-names>P.</given-names></name><name><surname>Hausfater</surname><given-names>P.</given-names></name><name><surname>Jaureguiberry</surname><given-names>S.</given-names></name><name><surname>Gay</surname><given-names>F.</given-names></name><name><surname>Datry</surname><given-names>A.</given-names></name><name><surname>Danis</surname><given-names>M.</given-names></name><name><surname>Bricaire</surname><given-names>F.</given-names></name><name><surname>Bossi</surname><given-names>P.</given-names></name></person-group><article-title>Cases of chikungunya fever imported from the islands of the South West Indian Ocean to Paris, France</article-title><source>Eurosurveillance</source><year>2007</year><volume>12</volume><fpage>13</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.2807/esm.12.01.00679-en</pub-id></element-citation></ref><ref id="B69-molecules-25-02796"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abubakar</surname><given-names>S.</given-names></name><name><surname>Sam</surname><given-names>I.C.</given-names></name><name><surname>Wong</surname><given-names>P.-F.</given-names></name><name><surname>Matrahim</surname><given-names>N.</given-names></name><name><surname>Hooi</surname><given-names>P.-S.</given-names></name><name><surname>Roslan</surname><given-names>N.</given-names></name></person-group><article-title>Reemergence of Endemic Chikungunya, Malaysia</article-title><source>Emerg. Infect. Dis.</source><year>2007</year><volume>13</volume><fpage>147</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.3201/eid1301.060617</pub-id><pub-id pub-id-type="pmid">17370532</pub-id></element-citation></ref><ref id="B70-molecules-25-02796"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanciotti</surname><given-names>R.S.</given-names></name><name><surname>Kosoy</surname><given-names>O.L.</given-names></name><name><surname>Laven</surname><given-names>J.J.</given-names></name><name><surname>Panella</surname><given-names>A.J.</given-names></name><name><surname>Velez</surname><given-names>J.O.</given-names></name><name><surname>Lambert</surname><given-names>A.J.</given-names></name><name><surname>Campbell</surname><given-names>G.L.</given-names></name></person-group><article-title>Chikungunya Virus in US Travelers Returning from India, 2006</article-title><source>Emerg. Infect. Dis.</source><year>2007</year><volume>13</volume><fpage>764</fpage><lpage>767</lpage><pub-id pub-id-type="doi">10.3201/eid1305.070015</pub-id><pub-id pub-id-type="pmid">17553261</pub-id></element-citation></ref><ref id="B71-molecules-25-02796"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azevedo</surname><given-names>R.S.S.</given-names></name><name><surname>Silva</surname><given-names>E.V.P.</given-names></name><name><surname>Carvalho</surname><given-names>V.L.</given-names></name><name><surname>Rodrigues</surname><given-names>S.G.</given-names></name><name><surname>Nunes Neto</surname><given-names>J.P.</given-names></name><name><surname>Monteiro</surname><given-names>H.A.O.</given-names></name><name><surname>Peixoto</surname><given-names>V.S.</given-names></name><name><surname>Chiang</surname><given-names>J.O.</given-names></name><name><surname>Nunes</surname><given-names>M.R.T.</given-names></name><name><surname>Vasconcelos</surname><given-names>P.F.C.</given-names></name></person-group><article-title>Mayaro Fever Virus, Brazilian Amazon</article-title><source>Emerg. Infect. Dis.</source><year>2009</year><volume>15</volume><fpage>1830</fpage><pub-id pub-id-type="doi">10.3201/eid1511.090461</pub-id><pub-id pub-id-type="pmid">19891877</pub-id></element-citation></ref><ref id="B72-molecules-25-02796"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auguste</surname><given-names>A.J.</given-names></name><name><surname>Liria</surname><given-names>J.</given-names></name><name><surname>Forrester</surname><given-names>N.L.</given-names></name><name><surname>Giambalvo</surname><given-names>D.</given-names></name><name><surname>Moncada</surname><given-names>M.</given-names></name><name><surname>Long</surname><given-names>K.C.</given-names></name><name><surname>Mor&#x000f3;n</surname><given-names>D.</given-names></name><name><surname>de Manzione</surname><given-names>N.</given-names></name><name><surname>Tesh</surname><given-names>R.B.</given-names></name><name><surname>Halsey</surname><given-names>E.S.</given-names></name><etal/></person-group><article-title>Evolutionary and Ecological Characterization of Mayaro Virus Strains Isolated during an Outbreak, Venezuela, 2010</article-title><source>Emerg. Infect. Dis.</source><year>2015</year><volume>21</volume><fpage>1742</fpage><lpage>1750</lpage><pub-id pub-id-type="doi">10.3201/eid2110.141660</pub-id><pub-id pub-id-type="pmid">26401714</pub-id></element-citation></ref><ref id="B73-molecules-25-02796"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuchi</surname><given-names>N.</given-names></name><name><surname>Heinen</surname><given-names>L.B.D.S.</given-names></name><name><surname>Santos</surname><given-names>M.A.M.D.</given-names></name><name><surname>Pereira</surname><given-names>F.C.</given-names></name><name><surname>Slhessarenko</surname><given-names>R.D.</given-names></name></person-group><article-title>Molecular detection of Mayaro virus during a dengue outbreak in the state of Mato Grosso, Central-West Brazil</article-title><source>Mem. Inst. Oswaldo Cruz</source><year>2014</year><volume>109</volume><fpage>820</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.1590/0074-0276140108</pub-id><pub-id pub-id-type="pmid">25141284</pub-id></element-citation></ref><ref id="B74-molecules-25-02796"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>K.C.</given-names></name><name><surname>Ziegler</surname><given-names>S.A.</given-names></name><name><surname>Thangamani</surname><given-names>S.</given-names></name><name><surname>Hausser</surname><given-names>N.L.</given-names></name><name><surname>Kocher</surname><given-names>T.J.</given-names></name><name><surname>Higgs</surname><given-names>S.</given-names></name><name><surname>Tesh</surname><given-names>R.B.</given-names></name></person-group><article-title>Experimental Transmission of Mayaro Virus by Aedes aegypti</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2011</year><volume>85</volume><fpage>750</fpage><lpage>757</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.2011.11-0359</pub-id><?supplied-pmid 21976583?><pub-id pub-id-type="pmid">21976583</pub-id></element-citation></ref><ref id="B75-molecules-25-02796"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halsey</surname><given-names>E.S.</given-names></name><name><surname>Siles</surname><given-names>C.</given-names></name><name><surname>Guevara</surname><given-names>C.</given-names></name><name><surname>Vilcarromero</surname><given-names>S.</given-names></name><name><surname>Jhonston</surname><given-names>E.J.</given-names></name><name><surname>Ramal</surname><given-names>C.</given-names></name><name><surname>Aguilar</surname><given-names>P.V.</given-names></name><name><surname>Ampuero</surname><given-names>J.S.</given-names></name></person-group><article-title>Mayaro Virus Infection, Amazon Basin region, Peru, 2010&#x02013;2013</article-title><source>Emerg. Infect. Dis.</source><year>2013</year><volume>19</volume><fpage>1839</fpage><pub-id pub-id-type="doi">10.3201/eid1911.130777</pub-id><?supplied-pmid 24210165?><pub-id pub-id-type="pmid">24210165</pub-id></element-citation></ref><ref id="B76-molecules-25-02796"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Oliveira Mota</surname><given-names>M.T.</given-names></name><name><surname>Ribeiro</surname><given-names>M.R.</given-names></name><name><surname>Vedovello</surname><given-names>D.</given-names></name><name><surname>Nogueira</surname><given-names>M.L.</given-names></name></person-group><article-title>Mayaro virus: A neglected arbovirus of the Americas</article-title><source>Future Virol.</source><year>2015</year><volume>10</volume><fpage>1109</fpage><lpage>1122</lpage><pub-id pub-id-type="doi">10.2217/fvl.15.76</pub-id></element-citation></ref><ref id="B77-molecules-25-02796"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieira</surname><given-names>C.J.d.S.P.</given-names></name><name><surname>Silva</surname><given-names>D.J.F.d.</given-names></name><name><surname>Barreto</surname><given-names>E.S.</given-names></name><name><surname>Siqueira</surname><given-names>C.E.H.</given-names></name><name><surname>Colombo</surname><given-names>T.E.</given-names></name><name><surname>Ozanic</surname><given-names>K.</given-names></name><name><surname>Schmidt</surname><given-names>D.J.</given-names></name><name><surname>Drumond</surname><given-names>B.P.</given-names></name><name><surname>Mondini</surname><given-names>A.</given-names></name><name><surname>Nogueira</surname><given-names>M.L.</given-names></name><etal/></person-group><article-title>Detection of Mayaro virus infections during a dengue outbreak in Mato Grosso, Brazil</article-title><source>Acta Trop.</source><year>2015</year><volume>147</volume><fpage>12</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.actatropica.2015.03.020</pub-id><pub-id pub-id-type="pmid">25817238</pub-id></element-citation></ref><ref id="B78-molecules-25-02796"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackay</surname><given-names>I.M.</given-names></name><name><surname>Arden</surname><given-names>K.E.</given-names></name></person-group><article-title>Mayaro virus: A forest virus primed for a trip to the city?</article-title><source>Microbes Infect.</source><year>2016</year><volume>18</volume><fpage>724</fpage><lpage>734</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2016.10.007</pub-id><?supplied-pmid 27989728?><pub-id pub-id-type="pmid">27989728</pub-id></element-citation></ref><ref id="B79-molecules-25-02796"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotez</surname><given-names>P.J.</given-names></name><name><surname>Murray</surname><given-names>K.O.</given-names></name></person-group><article-title>Dengue, West Nile virus, chikungunya, Zika-and now Mayaro?</article-title><source>PLoS Negl. Trop. Dis.</source><year>2017</year><volume>11</volume><elocation-id>e0005462</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0005462</pub-id><pub-id pub-id-type="pmid">28859086</pub-id></element-citation></ref><ref id="B80-molecules-25-02796"><label>80.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>WHO Traditional Medicine Strategy 2002&#x02013;2005</source><publisher-name>WHO</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2002</year></element-citation></ref><ref id="B81-molecules-25-02796"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clain</surname><given-names>E.</given-names></name><name><surname>Sinigaglia</surname><given-names>L.</given-names></name><name><surname>Koishi</surname><given-names>A.C.</given-names></name><name><surname>Gorgette</surname><given-names>O.</given-names></name><name><surname>Gadea</surname><given-names>G.</given-names></name><name><surname>Viranaicken</surname><given-names>W.</given-names></name><name><surname>Krejbich-Trotot</surname><given-names>P.</given-names></name><name><surname>Mavingui</surname><given-names>P.</given-names></name><name><surname>Despr&#x000e8;s</surname><given-names>P.</given-names></name><name><surname>dos Santos</surname><given-names>C.N.D.</given-names></name><etal/></person-group><article-title>Extract from <italic>Aphloia theiformis</italic>, an edible indigenous plant from Reunion Island, impairs Zika virus attachment to the host cell surface</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1038/s41598-018-29183-2</pub-id><pub-id pub-id-type="pmid">29311619</pub-id></element-citation></ref><ref id="B82-molecules-25-02796"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dos Santos</surname><given-names>A.E.</given-names></name><name><surname>Kuster</surname><given-names>R.M.</given-names></name><name><surname>Yamamoto</surname><given-names>K.A.</given-names></name><name><surname>Salles</surname><given-names>T.S.</given-names></name><name><surname>Campos</surname><given-names>R.</given-names></name><name><surname>De Meneses</surname><given-names>M.D.</given-names></name><name><surname>Soares</surname><given-names>M.R.</given-names></name><name><surname>Ferreira</surname><given-names>D.</given-names></name></person-group><article-title>Quercetin and quercetin 3-O-glycosides from <italic>Bauhinia longifolia</italic> (Bong.) Steud. show anti-Mayaro virus activity</article-title><source>Parasites Vectors</source><year>2014</year><volume>7</volume><fpage>130</fpage><pub-id pub-id-type="doi">10.1186/1756-3305-7-130</pub-id><pub-id pub-id-type="pmid">24678592</pub-id></element-citation></ref><ref id="B83-molecules-25-02796"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johari</surname><given-names>J.</given-names></name><name><surname>Kianmehr</surname><given-names>A.</given-names></name><name><surname>Mustafa</surname><given-names>M.</given-names></name><name><surname>Abubakar</surname><given-names>S.</given-names></name><name><surname>Zandi</surname><given-names>K.</given-names></name></person-group><article-title>Antiviral Activity of Baicalein and Quercetin against the Japanese Encephalitis Virus</article-title><source>Int. J. Mol. Sci.</source><year>2012</year><volume>13</volume><fpage>16785</fpage><lpage>16795</lpage><pub-id pub-id-type="doi">10.3390/ijms131216785</pub-id><pub-id pub-id-type="pmid">23222683</pub-id></element-citation></ref><ref id="B84-molecules-25-02796"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panche</surname><given-names>A.N.</given-names></name><name><surname>Diwan</surname><given-names>A.D.</given-names></name><name><surname>Chandra</surname><given-names>S.R.</given-names></name></person-group><article-title>Flavonoids: An overview</article-title><source>J. Nutr. Sci.</source><year>2016</year><volume>5</volume><pub-id pub-id-type="doi">10.1017/jns.2016.41</pub-id></element-citation></ref><ref id="B85-molecules-25-02796"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cushnie</surname><given-names>T.P.T.</given-names></name><name><surname>Lamb</surname><given-names>A.J.</given-names></name></person-group><article-title>Recent advances in understanding the antibacterial properties of flavonoids</article-title><source>Int. J. Antimicrob. Agents</source><year>2011</year><volume>38</volume><fpage>99</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2011.02.014</pub-id><?supplied-pmid 21514796?><pub-id pub-id-type="pmid">21514796</pub-id></element-citation></ref><ref id="B86-molecules-25-02796"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice-Evans</surname><given-names>C.</given-names></name></person-group><article-title>Flavonoid Antioxidants</article-title><source>Curr. Med. Chem.</source><year>2001</year><volume>8</volume><fpage>797</fpage><lpage>807</lpage><pub-id pub-id-type="doi">10.2174/0929867013373011</pub-id><?supplied-pmid 11375750?><pub-id pub-id-type="pmid">11375750</pub-id></element-citation></ref><ref id="B87-molecules-25-02796"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orhan</surname><given-names>D.D.</given-names></name><name><surname>&#x000d6;z&#x000e7;elik</surname><given-names>B.</given-names></name><name><surname>&#x000d6;zgen</surname><given-names>S.</given-names></name><name><surname>Ergun</surname><given-names>F.</given-names></name></person-group><article-title>Antibacterial, antifungal, and antiviral activities of some flavonoids</article-title><source>Microbiol. Res.</source><year>2010</year><volume>165</volume><fpage>496</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1016/j.micres.2009.09.002</pub-id><?supplied-pmid 19840899?><pub-id pub-id-type="pmid">19840899</pub-id></element-citation></ref><ref id="B88-molecules-25-02796"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaul</surname><given-names>T.N.</given-names></name><name><surname>Middleton</surname><given-names>E.</given-names></name><name><surname>Ogra</surname><given-names>P.L.</given-names></name></person-group><article-title>Antiviral Effect of Flavonoids on Human Viruses</article-title><source>J. Med. Virol.</source><year>1985</year><volume>15</volume><fpage>71</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1002/jmv.1890150110</pub-id><?supplied-pmid 2981979?><pub-id pub-id-type="pmid">2981979</pub-id></element-citation></ref><ref id="B89-molecules-25-02796"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manach</surname><given-names>C.</given-names></name><name><surname>Scalbert</surname><given-names>A.</given-names></name><name><surname>Morand</surname><given-names>C.</given-names></name><name><surname>R&#x000e9;m&#x000e9;sy</surname><given-names>C.</given-names></name><name><surname>Jim&#x000e9;nez</surname><given-names>L.</given-names></name></person-group><article-title>Polyphenols: Food sources and bioavailability</article-title><source>Am. J. Clin. Nutr.</source><year>2004</year><volume>79</volume><fpage>727</fpage><lpage>747</lpage><pub-id pub-id-type="doi">10.1093/ajcn/79.5.727</pub-id><?supplied-pmid 15113710?><pub-id pub-id-type="pmid">15113710</pub-id></element-citation></ref><ref id="B90-molecules-25-02796"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>K.B.</given-names></name><name><surname>Rizvi</surname><given-names>S.I.</given-names></name></person-group><article-title>Plant polyphenols as dietary antioxidants in human health and disease</article-title><source>Oxid. Med. Cell. Longev.</source><year>2009</year><volume>2</volume><fpage>270</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.4161/oxim.2.5.9498</pub-id><pub-id pub-id-type="pmid">20716914</pub-id></element-citation></ref><ref id="B91-molecules-25-02796"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chahar</surname><given-names>M.K.</given-names></name><name><surname>Sharma</surname><given-names>N.</given-names></name><name><surname>Dobhal</surname><given-names>M.P.</given-names></name><name><surname>Joshi</surname><given-names>Y.C.</given-names></name></person-group><article-title>Flavonoids: A versatile source of anticancer drugs</article-title><source>Pharmacogn. Rev.</source><year>2011</year><volume>5</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.4103/0973-7847.79093</pub-id><?supplied-pmid 22096313?><pub-id pub-id-type="pmid">22096313</pub-id></element-citation></ref><ref id="B92-molecules-25-02796"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>V&#x000e1;zquez-Calvo</surname><given-names>&#x000c1;.</given-names></name><name><surname>Jim&#x000e9;nez de Oya</surname><given-names>N.</given-names></name><name><surname>Mart&#x000ed;n-Acebes</surname><given-names>M.A.</given-names></name><name><surname>Garcia-Moruno</surname><given-names>E.</given-names></name><name><surname>Saiz</surname><given-names>J.-C.</given-names></name></person-group><article-title>Antiviral Properties of the Natural Polyphenols Delphinidin and Epigallocatechin Gallate against the Flaviviruses West Nile Virus, Zika Virus, and Dengue Virus</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><pub-id pub-id-type="doi">10.3389/fmicb.2017.01314</pub-id></element-citation></ref><ref id="B93-molecules-25-02796"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colpitts</surname><given-names>C.C.</given-names></name><name><surname>Schang</surname><given-names>L.M.</given-names></name></person-group><article-title>A Small Molecule Inhibits Virion Attachment to Heparan Sulfate- or Sialic Acid-Containing Glycans</article-title><source>J. Virol.</source><year>2014</year><volume>88</volume><fpage>7806</fpage><lpage>7817</lpage><pub-id pub-id-type="doi">10.1128/JVI.00896-14</pub-id><?supplied-pmid 24789779?><pub-id pub-id-type="pmid">24789779</pub-id></element-citation></ref><ref id="B94-molecules-25-02796"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anand</surname><given-names>P.</given-names></name><name><surname>Thomas</surname><given-names>S.G.</given-names></name><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Sundaram</surname><given-names>C.</given-names></name><name><surname>Harikumar</surname><given-names>K.B.</given-names></name><name><surname>Sung</surname><given-names>B.</given-names></name><name><surname>Tharakan</surname><given-names>S.T.</given-names></name><name><surname>Misra</surname><given-names>K.</given-names></name><name><surname>Priyadarsini</surname><given-names>I.K.</given-names></name><name><surname>Rajasekharan</surname><given-names>K.N.</given-names></name><etal/></person-group><article-title>Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature</article-title><source>Biochem. Pharmacol.</source><year>2008</year><volume>76</volume><fpage>1590</fpage><lpage>1611</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2008.08.008</pub-id><?supplied-pmid 18775680?><pub-id pub-id-type="pmid">18775680</pub-id></element-citation></ref><ref id="B95-molecules-25-02796"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lani</surname><given-names>R.</given-names></name><name><surname>Hassandarvish</surname><given-names>P.</given-names></name><name><surname>Shu</surname><given-names>M.-H.</given-names></name><name><surname>Phoon</surname><given-names>W.H.</given-names></name><name><surname>Chu</surname><given-names>J.J.H.</given-names></name><name><surname>Higgs</surname><given-names>S.</given-names></name><name><surname>Vanlandingham</surname><given-names>D.</given-names></name><name><surname>Abu Bakar</surname><given-names>S.</given-names></name><name><surname>Zandi</surname><given-names>K.</given-names></name></person-group><article-title>Antiviral activity of selected flavonoids against Chikungunya virus</article-title><source>Antivir. Res.</source><year>2016</year><volume>133</volume><fpage>50</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2016.07.009</pub-id><?supplied-pmid 27460167?><pub-id pub-id-type="pmid">27460167</pub-id></element-citation></ref><ref id="B96-molecules-25-02796"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moghaddam</surname><given-names>E.</given-names></name><name><surname>Teoh</surname><given-names>B.-T.</given-names></name><name><surname>Sam</surname><given-names>S.-S.</given-names></name><name><surname>Lani</surname><given-names>R.</given-names></name><name><surname>Hassandarvish</surname><given-names>P.</given-names></name><name><surname>Chik</surname><given-names>Z.</given-names></name><name><surname>Yueh</surname><given-names>A.</given-names></name><name><surname>Abubakar</surname><given-names>S.</given-names></name><name><surname>Zandi</surname><given-names>K.</given-names></name></person-group><article-title>Baicalin, a metabolite of baicalein with antiviral activity against dengue virus</article-title><source>Sci. Rep.</source><year>2014</year><volume>4</volume><fpage>5452</fpage><pub-id pub-id-type="doi">10.1038/srep05452</pub-id><?supplied-pmid 24965553?><pub-id pub-id-type="pmid">24965553</pub-id></element-citation></ref><ref id="B97-molecules-25-02796"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balasubramanian</surname><given-names>A.</given-names></name><name><surname>Pilankatta</surname><given-names>R.</given-names></name><name><surname>Teramoto</surname><given-names>T.</given-names></name><name><surname>Sajith</surname><given-names>A.M.</given-names></name><name><surname>Nwulia</surname><given-names>E.</given-names></name><name><surname>Kulkarni</surname><given-names>A.</given-names></name><name><surname>Padmanabhan</surname><given-names>R.</given-names></name></person-group><article-title>Inhibition of dengue virus by curcuminoids</article-title><source>Antivir. Res.</source><year>2019</year><volume>162</volume><fpage>71</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2018.12.002</pub-id><?supplied-pmid 30529358?><pub-id pub-id-type="pmid">30529358</pub-id></element-citation></ref><ref id="B98-molecules-25-02796"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>T.-Y.</given-names></name><name><surname>Chen</surname><given-names>D.-Y.</given-names></name><name><surname>Wen</surname><given-names>H.-W.</given-names></name><name><surname>Ou</surname><given-names>J.-L.</given-names></name><name><surname>Chiou</surname><given-names>S.-S.</given-names></name><name><surname>Chen</surname><given-names>J.-M.</given-names></name><name><surname>Wong</surname><given-names>M.-L.</given-names></name><name><surname>Hsu</surname><given-names>W.-L.</given-names></name></person-group><article-title>Inhibition of enveloped viruses infectivity by curcumin</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e62482</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0062482</pub-id><?supplied-pmid 23658730?><pub-id pub-id-type="pmid">23658730</pub-id></element-citation></ref><ref id="B99-molecules-25-02796"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mounce</surname><given-names>B.C.</given-names></name><name><surname>Cesaro</surname><given-names>T.</given-names></name><name><surname>Carrau</surname><given-names>L.</given-names></name><name><surname>Vallet</surname><given-names>T.</given-names></name><name><surname>Vignuzzi</surname><given-names>M.</given-names></name></person-group><article-title>Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding</article-title><source>Antivir. Res.</source><year>2017</year><volume>142</volume><fpage>148</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2017.03.014</pub-id><pub-id pub-id-type="pmid">28343845</pub-id></element-citation></ref><ref id="B100-molecules-25-02796"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>C.</given-names></name><name><surname>Sliva</surname><given-names>K.</given-names></name><name><surname>Von Rhein</surname><given-names>C.</given-names></name><name><surname>K&#x000fc;mmerer</surname><given-names>B.M.</given-names></name><name><surname>Schnierle</surname><given-names>B.S.</given-names></name></person-group><article-title>The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection</article-title><source>Antivir. Res.</source><year>2015</year><volume>113</volume><fpage>1</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2014.11.001</pub-id><pub-id pub-id-type="pmid">25446334</pub-id></element-citation></ref><ref id="B101-molecules-25-02796"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carneiro</surname><given-names>B.M.</given-names></name><name><surname>Batista</surname><given-names>M.N.</given-names></name><name><surname>Braga</surname><given-names>A.C.S.</given-names></name><name><surname>Nogueira</surname><given-names>M.L.</given-names></name><name><surname>Rahal</surname><given-names>P.</given-names></name></person-group><article-title>The green tea molecule EGCG inhibits Zika virus entry</article-title><source>Virology</source><year>2016</year><volume>496</volume><fpage>215</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2016.06.012</pub-id><pub-id pub-id-type="pmid">27344138</pub-id></element-citation></ref><ref id="B102-molecules-25-02796"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>P.</given-names></name><name><surname>Thiruchelvan</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>R.C.H.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>K.C.</given-names></name><name><surname>Ng</surname><given-names>M.L.</given-names></name><name><surname>Chu</surname><given-names>J.J.H.</given-names></name></person-group><article-title>Inhibition of Chikungunya Virus Replication by Harringtonine, a Novel Antiviral That Suppresses Viral Protein Expression</article-title><source>Antimicrob. Agents Chemother.</source><year>2013</year><volume>57</volume><fpage>155</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1128/AAC.01467-12</pub-id><pub-id pub-id-type="pmid">23275491</pub-id></element-citation></ref><ref id="B103-molecules-25-02796"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>C.-Y.</given-names></name><name><surname>Chen</surname><given-names>S.-J.</given-names></name><name><surname>Wu</surname><given-names>H.-N.</given-names></name><name><surname>Ping</surname><given-names>Y.-H.</given-names></name><name><surname>Lin</surname><given-names>C.-Y.</given-names></name><name><surname>Shiuan</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>C.-L.</given-names></name><name><surname>Lee</surname><given-names>Y.-R.</given-names></name><name><surname>Huang</surname><given-names>K.-J.</given-names></name></person-group><article-title>Honokiol, a Lignan Biphenol Derived from the Magnolia Tree, Inhibits Dengue Virus Type 2 Infection</article-title><source>Viruses</source><year>2015</year><volume>7</volume><fpage>4894</fpage><lpage>4910</lpage><pub-id pub-id-type="doi">10.3390/v7092852</pub-id><pub-id pub-id-type="pmid">26378567</pub-id></element-citation></ref><ref id="B104-molecules-25-02796"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaudry</surname><given-names>A.</given-names></name><name><surname>Bos</surname><given-names>S.</given-names></name><name><surname>Viranaicken</surname><given-names>W.</given-names></name><name><surname>Roche</surname><given-names>M.</given-names></name><name><surname>Krejbich-Trotot</surname><given-names>P.</given-names></name><name><surname>Gadea</surname><given-names>G.</given-names></name><name><surname>Despr&#x000e8;s</surname><given-names>P.</given-names></name><name><surname>El-Kalamouni</surname><given-names>C.</given-names></name></person-group><article-title>The Flavonoid Isoquercitrin Precludes Initiation of Zika Virus Infection in Human Cells</article-title><source>Int. J. Mol. Sci.</source><year>2018</year><volume>19</volume><elocation-id>1093</elocation-id><pub-id pub-id-type="doi">10.3390/ijms19041093</pub-id></element-citation></ref><ref id="B105-molecules-25-02796"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Du</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>F.</given-names></name><name><surname>Jin</surname><given-names>Q.</given-names></name></person-group><article-title>Anti-Japanese-Encephalitis-Viral Effects of Kaempferol and Daidzin and Their RNA-Binding Characteristics</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><elocation-id>e30259</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0030259</pub-id><?supplied-pmid 22276167?><pub-id pub-id-type="pmid">22276167</pub-id></element-citation></ref><ref id="B106-molecules-25-02796"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frabasile</surname><given-names>S.</given-names></name><name><surname>Koishi</surname><given-names>A.C.</given-names></name><name><surname>Kuczera</surname><given-names>D.</given-names></name><name><surname>Silveira</surname><given-names>G.F.</given-names></name><name><surname>Verri</surname><given-names>W.A.</given-names><suffix>Jr.</suffix></name><name><surname>Duarte Dos Santos</surname><given-names>C.N.</given-names></name><name><surname>Bordignon</surname><given-names>J.</given-names></name></person-group><article-title>The citrus flavanone naringenin impairs dengue virus replication in human cells</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>41864</fpage><pub-id pub-id-type="doi">10.1038/srep41864</pub-id><?supplied-pmid 28157234?><pub-id pub-id-type="pmid">28157234</pub-id></element-citation></ref><ref id="B107-molecules-25-02796"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.L.</given-names></name><name><surname>Loe</surname><given-names>M.W.C.</given-names></name><name><surname>Lee</surname><given-names>R.C.H.</given-names></name><name><surname>Chu</surname><given-names>J.J.H.</given-names></name></person-group><article-title>Antiviral activity of pinocembrin against Zika virus replication</article-title><source>Antivir. Res.</source><year>2019</year><volume>167</volume><fpage>13</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2019.04.003</pub-id><?supplied-pmid 30959074?><pub-id pub-id-type="pmid">30959074</pub-id></element-citation></ref><ref id="B108-molecules-25-02796"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zandi</surname><given-names>K.</given-names></name><name><surname>Teoh</surname><given-names>B.-T.</given-names></name><name><surname>Sam</surname><given-names>S.-S.</given-names></name><name><surname>Wong</surname><given-names>P.-F.</given-names></name><name><surname>Mustafa</surname><given-names>M.R.</given-names></name><name><surname>Abubakar</surname><given-names>S.</given-names></name></person-group><article-title>Antiviral activity of four types of bioflavonoid against dengue virus type-2</article-title><source>Virol. J.</source><year>2011</year><volume>8</volume><fpage>560</fpage><pub-id pub-id-type="doi">10.1186/1743-422X-8-560</pub-id><?supplied-pmid 22201648?><pub-id pub-id-type="pmid">22201648</pub-id></element-citation></ref><ref id="B109-molecules-25-02796"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malakar</surname><given-names>S.</given-names></name><name><surname>Sreelatha</surname><given-names>L.</given-names></name><name><surname>Dechtawewat</surname><given-names>T.</given-names></name><name><surname>Noisakran</surname><given-names>S.</given-names></name><name><surname>Yenchitsomanus</surname><given-names>P.-T.</given-names></name><name><surname>Chu</surname><given-names>J.J.H.</given-names></name><name><surname>Limjindaporn</surname><given-names>T.</given-names></name></person-group><article-title>Drug repurposing of quinine as antiviral against dengue virus infection</article-title><source>Virus Res.</source><year>2018</year><volume>255</volume><fpage>171</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2018.07.018</pub-id><pub-id pub-id-type="pmid">30055216</pub-id></element-citation></ref><ref id="B110-molecules-25-02796"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohd</surname><given-names>A.</given-names></name><name><surname>Zainal</surname><given-names>N.</given-names></name><name><surname>Tan</surname><given-names>K.-K.</given-names></name><name><surname>Abubakar</surname><given-names>S.</given-names></name></person-group><article-title>Resveratrol affects Zika virus replication in vitro</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><pub-id pub-id-type="doi">10.1038/s41598-019-50674-3</pub-id></element-citation></ref><ref id="B111-molecules-25-02796"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.K.</given-names></name><name><surname>Chui</surname><given-names>J.L.M.</given-names></name><name><surname>Lee</surname><given-names>R.C.H.</given-names></name><name><surname>Kong</surname><given-names>H.Y.</given-names></name><name><surname>Chin</surname><given-names>W.-X.</given-names></name><name><surname>Chu</surname><given-names>J.J.H.</given-names></name></person-group><article-title>Antiviral activity of ST081006 against the dengue virus</article-title><source>Antivir. Res.</source><year>2019</year><volume>171</volume><fpage>104589</fpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2019.104589</pub-id><pub-id pub-id-type="pmid">31421165</pub-id></element-citation></ref><ref id="B112-molecules-25-02796"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellan</surname><given-names>K.</given-names></name><name><surname>Thayan</surname><given-names>R.</given-names></name><name><surname>Raman</surname><given-names>J.</given-names></name><name><surname>Hidari</surname><given-names>K.I.P.J.</given-names></name><name><surname>Ismail</surname><given-names>N.</given-names></name><name><surname>Sabaratnam</surname><given-names>V.</given-names></name></person-group><article-title>Anti-viral activity of culinary and medicinal mushroom extracts against dengue virus serotype 2: An in-vitro study</article-title><source>BMC Complement. Altern. Med.</source><year>2019</year><volume>19</volume><fpage>260</fpage><pub-id pub-id-type="doi">10.1186/s12906-019-2629-y</pub-id><pub-id pub-id-type="pmid">31533688</pub-id></element-citation></ref><ref id="B113-molecules-25-02796"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clain</surname><given-names>E.</given-names></name><name><surname>Haddad</surname><given-names>J.G.</given-names></name><name><surname>Koishi</surname><given-names>A.C.</given-names></name><name><surname>Sinigaglia</surname><given-names>L.</given-names></name><name><surname>Rachidi</surname><given-names>W.</given-names></name><name><surname>Despr&#x000e8;s</surname><given-names>P.</given-names></name><name><surname>Duarte Dos Santos</surname><given-names>C.N.</given-names></name><name><surname>Guiraud</surname><given-names>P.</given-names></name><name><surname>Jouvenet</surname><given-names>N.</given-names></name><name><surname>El Kalamouni</surname><given-names>C.</given-names></name></person-group><article-title>The Polyphenol-Rich Extract from <italic>Psiloxylon mauritianum</italic>, an Endemic Medicinal Plant from Reunion Island, Inhibits the Early Stages of Dengue and Zika Virus Infection</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>1860</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20081860</pub-id></element-citation></ref><ref id="B114-molecules-25-02796"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lani</surname><given-names>R.</given-names></name><name><surname>Hassandarvish</surname><given-names>P.</given-names></name><name><surname>Chiam</surname><given-names>C.W.</given-names></name><name><surname>Moghaddam</surname><given-names>E.</given-names></name><name><surname>Chu</surname><given-names>J.J.H.</given-names></name><name><surname>Rausalu</surname><given-names>K.</given-names></name><name><surname>Merits</surname><given-names>A.</given-names></name><name><surname>Higgs</surname><given-names>S.</given-names></name><name><surname>Vanlandingham</surname><given-names>D.</given-names></name><name><surname>Abu Bakar</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Antiviral activity of silymarin against chikungunya virus</article-title><source>Sci. Rep.</source><year>2015</year><volume>5</volume><fpage>11421</fpage><pub-id pub-id-type="doi">10.1038/srep11421</pub-id><pub-id pub-id-type="pmid">26078201</pub-id></element-citation></ref><ref id="B115-molecules-25-02796"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camini</surname><given-names>F.C.</given-names></name><name><surname>da Silva</surname><given-names>T.F.</given-names></name><name><surname>da Silva Caetano</surname><given-names>C.C.</given-names></name><name><surname>Almeida</surname><given-names>L.T.</given-names></name><name><surname>Ferraz</surname><given-names>A.C.</given-names></name><name><surname>Alves Vitoreti</surname><given-names>V.M.</given-names></name><name><surname>de Mello Silva</surname><given-names>B.</given-names></name><name><surname>de Queiroz Silva</surname><given-names>S.</given-names></name><name><surname>de Magalhaes</surname><given-names>J.C.</given-names></name><name><surname>de Brito Magalhaes</surname><given-names>C.L.</given-names></name></person-group><article-title>Antiviral activity of silymarin against Mayaro virus and protective effect in virus-induced oxidative stress</article-title><source>Antivir. Res.</source><year>2018</year><volume>158</volume><fpage>8</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2018.07.023</pub-id><?supplied-pmid 30076863?><pub-id pub-id-type="pmid">30076863</pub-id></element-citation></ref><ref id="B116-molecules-25-02796"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epstein</surname><given-names>J.</given-names></name><name><surname>Sanderson</surname><given-names>I.R.</given-names></name><name><surname>MacDonald</surname><given-names>T.T.</given-names></name></person-group><article-title>Curcumin as a therapeutic agent: The evidence from in vitro, animal and human studies</article-title><source>Br. J. Nutr.</source><year>2010</year><volume>103</volume><fpage>1545</fpage><lpage>1557</lpage><pub-id pub-id-type="doi">10.1017/S0007114509993667</pub-id><?supplied-pmid 20100380?><pub-id pub-id-type="pmid">20100380</pub-id></element-citation></ref><ref id="B117-molecules-25-02796"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lao</surname><given-names>C.D.</given-names></name><name><surname>Ruffin</surname><given-names>M.T.</given-names></name><name><surname>Normolle</surname><given-names>D.</given-names></name><name><surname>Heath</surname><given-names>D.D.</given-names></name><name><surname>Murray</surname><given-names>S.I.</given-names></name><name><surname>Bailey</surname><given-names>J.M.</given-names></name><name><surname>Boggs</surname><given-names>M.E.</given-names></name><name><surname>Crowell</surname><given-names>J.</given-names></name><name><surname>Rock</surname><given-names>C.L.</given-names></name><name><surname>Brenner</surname><given-names>D.E.</given-names></name></person-group><article-title>Dose escalation of a curcuminoid formulation</article-title><source>BMC Complement. Altern. Med.</source><year>2006</year><volume>6</volume><pub-id pub-id-type="doi">10.1186/1472-6882-6-10</pub-id><?supplied-pmid 16545122?><pub-id pub-id-type="pmid">16545122</pub-id></element-citation></ref><ref id="B118-molecules-25-02796"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strimpakos</surname><given-names>A.S.</given-names></name><name><surname>Sharma</surname><given-names>R.A.</given-names></name></person-group><article-title>Curcumin: Preventive and therapeutic properties in laboratory studies and clinical trials</article-title><source>Antioxid. Redox Signal.</source><year>2008</year><volume>10</volume><fpage>511</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1089/ars.2007.1769</pub-id><?supplied-pmid 18370854?><pub-id pub-id-type="pmid">18370854</pub-id></element-citation></ref><ref id="B119-molecules-25-02796"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>R.A.</given-names></name></person-group><article-title>Phase I Clinical Trial of Oral Curcumin: Biomarkers of Systemic Activity and Compliance</article-title><source>Clin. Cancer Res.</source><year>2004</year><volume>10</volume><fpage>6847</fpage><lpage>6854</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-04-0744</pub-id><pub-id pub-id-type="pmid">15501961</pub-id></element-citation></ref><ref id="B120-molecules-25-02796"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colpitts</surname><given-names>C.C.</given-names></name><name><surname>Schang</surname><given-names>L.M.</given-names></name><name><surname>Rachmawati</surname><given-names>H.</given-names></name><name><surname>Frentzen</surname><given-names>A.</given-names></name><name><surname>Pfaender</surname><given-names>S.</given-names></name><name><surname>Behrendt</surname><given-names>P.</given-names></name><name><surname>Brown</surname><given-names>R.J.P.</given-names></name><name><surname>Bankwitz</surname><given-names>D.</given-names></name><name><surname>Steinmann</surname><given-names>J.</given-names></name><name><surname>Ott</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells</article-title><source>Gut</source><year>2014</year><volume>63</volume><fpage>1137</fpage><lpage>1149</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2012-304299</pub-id><pub-id pub-id-type="pmid">23903236</pub-id></element-citation></ref><ref id="B121-molecules-25-02796"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazumder</surname><given-names>A.</given-names></name><name><surname>Raghavan</surname><given-names>K.</given-names></name><name><surname>Weinstein</surname><given-names>J.</given-names></name><name><surname>Kohn</surname><given-names>K.W.</given-names></name><name><surname>Pommier</surname><given-names>Y.</given-names></name></person-group><article-title>Inhibition of human immunodeficiency virus type-1 integrase by curcumin</article-title><source>Biochem. Pharmacol.</source><year>1995</year><volume>49</volume><fpage>1165</fpage><lpage>1170</lpage><pub-id pub-id-type="doi">10.1016/0006-2952(95)98514-A</pub-id><pub-id pub-id-type="pmid">7748198</pub-id></element-citation></ref><ref id="B122-molecules-25-02796"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calland</surname><given-names>N.</given-names></name><name><surname>Albecka</surname><given-names>A.</given-names></name><name><surname>Belouzard</surname><given-names>S.</given-names></name><name><surname>Wychowski</surname><given-names>C.</given-names></name><name><surname>Duverlie</surname><given-names>G.</given-names></name><name><surname>Descamps</surname><given-names>V.</given-names></name><name><surname>Hober</surname><given-names>D.</given-names></name><name><surname>Dubuisson</surname><given-names>J.</given-names></name><name><surname>Rouill&#x000e9;</surname><given-names>Y.</given-names></name><name><surname>S&#x000e9;ron</surname><given-names>K.</given-names></name></person-group><article-title>(&#x02212;)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry</article-title><source>Hepatology</source><year>2012</year><volume>55</volume><fpage>720</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.1002/hep.24803</pub-id><pub-id pub-id-type="pmid">22105803</pub-id></element-citation></ref><ref id="B123-molecules-25-02796"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>K.</given-names></name><name><surname>Honda</surname><given-names>M.</given-names></name><name><surname>Ikigai</surname><given-names>H.</given-names></name><name><surname>Hara</surname><given-names>Y.</given-names></name><name><surname>Shimamura</surname><given-names>T.</given-names></name></person-group><article-title>Inhibitory effects of (&#x02212;)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1)</article-title><source>Antivir. Res.</source><year>2002</year><volume>53</volume><fpage>19</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/S0166-3542(01)00189-9</pub-id><pub-id pub-id-type="pmid">11684313</pub-id></element-citation></ref><ref id="B124-molecules-25-02796"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weisburg</surname><given-names>J.H.</given-names></name><name><surname>Weissman</surname><given-names>D.B.</given-names></name><name><surname>Sedaghat</surname><given-names>T.</given-names></name><name><surname>Babich</surname><given-names>H.</given-names></name></person-group><article-title>In Vitro Cytotoxicity of Epigallocatechin Gallate and Tea Extracts to Cancerous and Normal Cells from the Human Oral Cavity</article-title><source>Basic Clin. Pharmacol. Toxicol.</source><year>2004</year><volume>95</volume><fpage>191</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1111/j.1742-7843.2004.pto_950407.x</pub-id><pub-id pub-id-type="pmid">15504155</pub-id></element-citation></ref><ref id="B125-molecules-25-02796"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>K.O.</given-names></name><name><surname>Wang</surname><given-names>C.C.</given-names></name><name><surname>Chu</surname><given-names>C.Y.</given-names></name><name><surname>Choy</surname><given-names>K.W.</given-names></name><name><surname>Pang</surname><given-names>C.P.</given-names></name><name><surname>Rogers</surname><given-names>M.S.</given-names></name></person-group><article-title>Uptake and distribution of catechins in fetal organs following in utero exposure in rats</article-title><source>Hum. Reprod.</source><year>2007</year><volume>22</volume><fpage>280</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1093/humrep/del353</pub-id><?supplied-pmid 16959805?><pub-id pub-id-type="pmid">16959805</pub-id></element-citation></ref><ref id="B126-molecules-25-02796"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lan</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name></person-group><article-title>The natural flavonoid pinocembrin: Molecular targets and potential therapeutic applications</article-title><source>Mol. Neurobiol.</source><year>2016</year><volume>53</volume><fpage>1794</fpage><lpage>1801</lpage><pub-id pub-id-type="doi">10.1007/s12035-015-9125-2</pub-id><pub-id pub-id-type="pmid">25744566</pub-id></element-citation></ref><ref id="B127-molecules-25-02796"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Luo</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name></person-group><article-title>Advances in Biosynthesis, Pharmacology, and Pharmacokinetics of Pinocembrin, a Promising Natural Small-Molecule Drug</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>2323</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24122323</pub-id></element-citation></ref><ref id="B128-molecules-25-02796"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z.-H.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Qi</surname><given-names>Y.</given-names></name><name><surname>Mei</surname><given-names>C.</given-names></name><name><surname>Sun</surname><given-names>X.-B.</given-names></name><name><surname>Du</surname><given-names>G.-H.</given-names></name></person-group><article-title>Uptake characteristics of pinocembrin and its effect on p-glycoprotein at the blood&#x02013;brain barrier inin vitrocell experiments</article-title><source>J. Asian Nat. Prod. Res.</source><year>2012</year><volume>14</volume><fpage>14</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1080/10286020.2011.620393</pub-id><?supplied-pmid 22263589?><pub-id pub-id-type="pmid">22263589</pub-id></element-citation></ref><ref id="B129-molecules-25-02796"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>G.</given-names></name><name><surname>Ying</surname><given-names>P.</given-names></name><name><surname>Yan</surname><given-names>B.</given-names></name><name><surname>Xue</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><name><surname>Shi</surname><given-names>A.</given-names></name><name><surname>Sun</surname><given-names>T.</given-names></name><name><surname>Yan</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name></person-group><article-title>Pharmacokinetics, safety, and tolerability of single and multiple-doses of pinocembrin injection administered intravenously in healthy subjects</article-title><source>J. Ethnopharmacol.</source><year>2015</year><volume>168</volume><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2015.03.041</pub-id><?supplied-pmid 25814318?><pub-id pub-id-type="pmid">25814318</pub-id></element-citation></ref><ref id="B130-molecules-25-02796"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Achan</surname><given-names>J.</given-names></name><name><surname>Talisuna</surname><given-names>A.O.</given-names></name><name><surname>Erhart</surname><given-names>A.</given-names></name><name><surname>Yeka</surname><given-names>A.</given-names></name><name><surname>Tibenderana</surname><given-names>J.K.</given-names></name><name><surname>Baliraine</surname><given-names>F.N.</given-names></name><name><surname>Rosenthal</surname><given-names>P.J.</given-names></name><name><surname>D&#x02019;Alessandro</surname><given-names>U.</given-names></name></person-group><article-title>Quinine, an old anti-malarial drug in a modern world: Role in the treatment of malaria</article-title><source>Malar. J.</source><year>2011</year><volume>10</volume><fpage>144</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-10-144</pub-id><?supplied-pmid 21609473?><pub-id pub-id-type="pmid">21609473</pub-id></element-citation></ref><ref id="B131-molecules-25-02796"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baroni</surname><given-names>A.</given-names></name><name><surname>Paoletti</surname><given-names>I.</given-names></name><name><surname>Ruocco</surname><given-names>E.</given-names></name><name><surname>Ayala</surname><given-names>F.</given-names></name><name><surname>Corrado</surname><given-names>F.</given-names></name><name><surname>Wolf</surname><given-names>R.</given-names></name><name><surname>Tufano</surname><given-names>M.A.</given-names></name><name><surname>Donnarumma</surname><given-names>G.</given-names></name></person-group><article-title>Antiviral effects of quinine sulfate on HSV-1 HaCat cells infected: Analysis of the molecular mechanisms involved</article-title><source>J. Dermatol. Sci.</source><year>2007</year><volume>47</volume><fpage>253</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1016/j.jdermsci.2007.05.009</pub-id><pub-id pub-id-type="pmid">17600687</pub-id></element-citation></ref><ref id="B132-molecules-25-02796"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marois</surname><given-names>I.</given-names></name><name><surname>Cloutier</surname><given-names>A.</given-names></name><name><surname>Meunier</surname><given-names>I.</given-names></name><name><surname>Weingartl</surname><given-names>H.M.</given-names></name><name><surname>Cantin</surname><given-names>A.M.</given-names></name><name><surname>Richter</surname><given-names>M.V.</given-names></name></person-group><article-title>Inhibition of Influenza Virus Replication by Targeting Broad Host Cell Pathways</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e110631</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0110631</pub-id><pub-id pub-id-type="pmid">25333287</pub-id></element-citation></ref><ref id="B133-molecules-25-02796"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashburn</surname><given-names>T.T.</given-names></name><name><surname>Thor</surname><given-names>K.B.</given-names></name></person-group><article-title>Drug repositioning: Identifying and developing new uses for existing drugs</article-title><source>Nat. Rev. Drug Discov.</source><year>2004</year><volume>3</volume><fpage>673</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1038/nrd1468</pub-id><pub-id pub-id-type="pmid">15286734</pub-id></element-citation></ref><ref id="B134-molecules-25-02796"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Federico</surname><given-names>A.</given-names></name><name><surname>Dallio</surname><given-names>M.</given-names></name><name><surname>Loguercio</surname><given-names>C.</given-names></name></person-group><article-title>Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years</article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>191</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22020191</pub-id></element-citation></ref><ref id="B135-molecules-25-02796"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunnick</surname><given-names>J.K.</given-names></name><name><surname>Singh</surname><given-names>B.</given-names></name><name><surname>Nyska</surname><given-names>A.</given-names></name><name><surname>Peckham</surname><given-names>J.</given-names></name><name><surname>Kissling</surname><given-names>G.E.</given-names></name><name><surname>Sanders</surname><given-names>J.M.</given-names></name></person-group><article-title>Investigating the Potential for Toxicity from Long-Term Use of the Herbal Products, Goldenseal and Milk Thistle</article-title><source>Toxicol. Pathol.</source><year>2011</year><volume>39</volume><fpage>398</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1177/0192623310394211</pub-id><?supplied-pmid 21300790?><pub-id pub-id-type="pmid">21300790</pub-id></element-citation></ref><ref id="B136-molecules-25-02796"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saller</surname><given-names>R.</given-names></name><name><surname>Brignoli</surname><given-names>R.</given-names></name><name><surname>Melzer</surname><given-names>J.</given-names></name><name><surname>Meier</surname><given-names>R.</given-names></name></person-group><article-title>An Updated Systematic Review with Meta-Analysis for the Clinical Evidence of Silymarin</article-title><source>Complement. Med. Res.</source><year>2008</year><volume>15</volume><fpage>9</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1159/000113648</pub-id><?supplied-pmid 18334810?><pub-id pub-id-type="pmid">18334810</pub-id></element-citation></ref><ref id="B137-molecules-25-02796"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagoner</surname><given-names>J.</given-names></name><name><surname>Negash</surname><given-names>A.</given-names></name><name><surname>Kane</surname><given-names>O.J.</given-names></name><name><surname>Martinez</surname><given-names>L.E.</given-names></name><name><surname>Nahmias</surname><given-names>Y.</given-names></name><name><surname>Bourne</surname><given-names>N.</given-names></name><name><surname>Owen</surname><given-names>D.M.</given-names></name><name><surname>Grove</surname><given-names>J.</given-names></name><name><surname>Brimacombe</surname><given-names>C.</given-names></name><name><surname>McKeating</surname><given-names>J.A.</given-names></name><etal/></person-group><article-title>Multiple effects of silymarin on the hepatitis C virus lifecycle</article-title><source>Hepatology</source><year>2010</year><volume>51</volume><fpage>1912</fpage><lpage>1921</lpage><pub-id pub-id-type="doi">10.1002/hep.23587</pub-id><pub-id pub-id-type="pmid">20512985</pub-id></element-citation></ref><ref id="B138-molecules-25-02796"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilder-Smith</surname><given-names>A.</given-names></name><name><surname>Vannice</surname><given-names>K.</given-names></name><name><surname>Durbin</surname><given-names>A.</given-names></name><name><surname>Hombach</surname><given-names>J.</given-names></name><name><surname>Thomas</surname><given-names>S.J.</given-names></name><name><surname>Irani</surname><given-names>T.</given-names></name><name><surname>Simmons</surname><given-names>C.P.</given-names></name></person-group><article-title>Zika vaccines and therapeutics: Landscape analysis and challenges ahead</article-title><source>BMC Med.</source><year>2018</year><volume>16</volume><elocation-id>84</elocation-id><pub-id pub-id-type="doi">10.1186/s12916-018-1067-x</pub-id><?supplied-pmid 29871628?><pub-id pub-id-type="pmid">29871628</pub-id></element-citation></ref><ref id="B139-molecules-25-02796"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saiz</surname><given-names>J.-C.</given-names></name><name><surname>Oya</surname><given-names>N.</given-names></name><name><surname>Bl&#x000e1;zquez</surname><given-names>A.-B.</given-names></name><name><surname>Escribano-Romero</surname><given-names>E.</given-names></name><name><surname>Mart&#x000ed;n-Acebes</surname><given-names>M.</given-names></name></person-group><article-title>Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus</article-title><source>Viruses</source><year>2018</year><volume>10</volume><elocation-id>453</elocation-id><pub-id pub-id-type="doi">10.3390/v10090453</pub-id><?supplied-pmid 30149598?><pub-id pub-id-type="pmid">30149598</pub-id></element-citation></ref><ref id="B140-molecules-25-02796"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiborr</surname><given-names>C.</given-names></name><name><surname>Kocher</surname><given-names>A.</given-names></name><name><surname>Behnam</surname><given-names>D.</given-names></name><name><surname>Jandasek</surname><given-names>J.</given-names></name><name><surname>Toelstede</surname><given-names>S.</given-names></name><name><surname>Frank</surname><given-names>J.</given-names></name></person-group><article-title>The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes</article-title><source>Mol. Nutr. Food Res.</source><year>2014</year><volume>58</volume><fpage>516</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1002/mnfr.201300724</pub-id><pub-id pub-id-type="pmid">24402825</pub-id></element-citation></ref><ref id="B141-molecules-25-02796"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>H.</given-names></name><name><surname>Sunagawa</surname><given-names>Y.</given-names></name><name><surname>Takahashi</surname><given-names>K.</given-names></name><name><surname>Imaizumi</surname><given-names>A.</given-names></name><name><surname>Fukuda</surname><given-names>H.</given-names></name><name><surname>Hashimoto</surname><given-names>T.</given-names></name><name><surname>Wada</surname><given-names>H.</given-names></name><name><surname>Katanasaka</surname><given-names>Y.</given-names></name><name><surname>Kakeya</surname><given-names>H.</given-names></name><name><surname>Fujita</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Innovative Preparation of Curcumin for Improved Oral Bioavailability</article-title><source>Biol. Pharm. Bull.</source><year>2011</year><volume>34</volume><fpage>660</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1248/bpb.34.660</pub-id><pub-id pub-id-type="pmid">21532153</pub-id></element-citation></ref><ref id="B142-molecules-25-02796"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>C.</given-names></name><name><surname>Peng</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Zou</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name></person-group><article-title>Improved bioavailability of curcumin in liposomes prepared using a pH-driven, organic solvent-free, easily scalable process</article-title><source>RSC Adv.</source><year>2017</year><volume>7</volume><fpage>25978</fpage><lpage>25986</lpage><pub-id pub-id-type="doi">10.1039/C7RA02861J</pub-id></element-citation></ref><ref id="B143-molecules-25-02796"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minnelli</surname><given-names>C.</given-names></name><name><surname>Laudadio</surname><given-names>E.</given-names></name><name><surname>Galeazzi</surname><given-names>R.</given-names></name><name><surname>Barucca</surname><given-names>G.</given-names></name><name><surname>Notarstefano</surname><given-names>V.</given-names></name><name><surname>Cantarini</surname><given-names>M.</given-names></name><name><surname>Armeni</surname><given-names>T.</given-names></name><name><surname>Mobbili</surname><given-names>G.</given-names></name></person-group><article-title>Encapsulation of a Neutral Molecule into a Cationic Clay Material: Structural Insight and Cytotoxicity of Resveratrol/Layered Double Hydroxide/BSA Nanocomposites</article-title><source>Nanomaterials</source><year>2019</year><volume>10</volume><elocation-id>33</elocation-id><pub-id pub-id-type="doi">10.3390/nano10010033</pub-id></element-citation></ref><ref id="B144-molecules-25-02796"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minnelli</surname><given-names>C.</given-names></name><name><surname>Galeazzi</surname><given-names>R.</given-names></name><name><surname>Laudadio</surname><given-names>E.</given-names></name><name><surname>Amici</surname><given-names>A.</given-names></name><name><surname>Rusciano</surname><given-names>D.</given-names></name><name><surname>Armeni</surname><given-names>T.</given-names></name><name><surname>Cantarini</surname><given-names>M.</given-names></name><name><surname>Stipa</surname><given-names>P.</given-names></name><name><surname>Mobbili</surname><given-names>G.</given-names></name></person-group><article-title>Monoalkylated Epigallocatechin-3-gallate (C18-EGCG) as Novel Lipophilic EGCG Derivative: Characterization and Antioxidant Evaluation</article-title><source>Antioxidants</source><year>2020</year><volume>9</volume><elocation-id>208</elocation-id><pub-id pub-id-type="doi">10.3390/antiox9030208</pub-id></element-citation></ref><ref id="B145-molecules-25-02796"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nekhai</surname><given-names>S.</given-names></name><name><surname>Kumari</surname><given-names>N.</given-names></name><name><surname>Kulkarni</surname><given-names>A.</given-names></name><name><surname>Lin</surname><given-names>X.</given-names></name><name><surname>McLean</surname><given-names>C.</given-names></name><name><surname>Ammosova</surname><given-names>T.</given-names></name><name><surname>Ivanov</surname><given-names>A.</given-names></name><name><surname>Hipolito</surname><given-names>M.</given-names></name><name><surname>Nwulia</surname><given-names>E.</given-names></name></person-group><article-title>Inhibition of HIV-1 by curcumin A, a novel curcumin analog</article-title><source>Drug Des. Dev. Ther.</source><year>2015</year><fpage>5051</fpage><lpage>5060</lpage><pub-id pub-id-type="doi">10.2147/DDDT.S86558</pub-id><?supplied-pmid 26366056?><pub-id pub-id-type="pmid">26366056</pub-id></element-citation></ref><ref id="B146-molecules-25-02796"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>A.-N.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>Y.-J.</given-names></name><name><surname>Xu</surname><given-names>X.-R.</given-names></name><name><surname>Chen</surname><given-names>Y.-M.</given-names></name><name><surname>Li</surname><given-names>H.-B.</given-names></name></person-group><article-title>Resources and Biological Activities of Natural Polyphenols</article-title><source>Nutrients</source><year>2014</year><volume>6</volume><fpage>6020</fpage><lpage>6047</lpage><pub-id pub-id-type="doi">10.3390/nu6126020</pub-id><?supplied-pmid 25533011?><pub-id pub-id-type="pmid">25533011</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="molecules-25-02796-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-02796-t001_Table 1</object-id><label>Table 1</label><caption><p>List of common arboviruses circulating in Asia</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Virus</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Family/Genus</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Transmission<break/>Vectors</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Symptoms</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Treatment Available?</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Vaccine Available?</th></tr></thead><tbody><tr><td align="center" valign="top" rowspan="1" colspan="1">DENV</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>Flaviviridae</italic><break/>(genus <italic>Flavivirus</italic>)</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>Aedes aegypti</italic> and <italic>Aedes albopticus</italic></td><td align="center" valign="top" rowspan="1" colspan="1">Fever, hemorrhagic fever.</td><td align="center" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="top" rowspan="1" colspan="1">Yes [<xref rid="B15-molecules-25-02796" ref-type="bibr">15</xref>]</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">JEV</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>Flaviviridae</italic><break/>(genus <italic>Flavivirus</italic>)</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>Culex</italic> spp.</td><td align="center" valign="top" rowspan="1" colspan="1">Fever, headache, seizures, encephalitis.</td><td align="center" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="top" rowspan="1" colspan="1">Yes [<xref rid="B16-molecules-25-02796" ref-type="bibr">16</xref>]</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">WNV</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>Flaviviridae</italic><break/>(genus <italic>Flavivirus</italic>)</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>Culex</italic> spp.</td><td align="center" valign="top" rowspan="1" colspan="1">Fever, muscle weakness, encephalitis, meningitis.</td><td align="center" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="top" rowspan="1" colspan="1">Not for humans. Vaccines for horses are available [<xref rid="B17-molecules-25-02796" ref-type="bibr">17</xref>,<xref rid="B18-molecules-25-02796" ref-type="bibr">18</xref>].</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">ZIKV</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>Flaviviridae</italic><break/>(genus <italic>Flavivirus</italic>)</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>Aedes</italic> spp.</td><td align="center" valign="top" rowspan="1" colspan="1">Fever, arthralgia, and myalgia. Neurological manifestations.</td><td align="center" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="top" rowspan="1" colspan="1">No</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">CHIKV</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Togaviridae</italic><break/>(genus <italic>Alphavirus</italic>)</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Aedes</italic> spp.</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Fever, arthralgia, and myalgia.</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td></tr></tbody></table></table-wrap><table-wrap id="molecules-25-02796-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-02796-t002_Table 2</object-id><label>Table 2</label><caption><p>List of natural compounds shown to exhibit antiviral properties against arboviruses (DENV, JEV, WNV, ZIKV, and CHIKV)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">S/N</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound Name/Chemical Structure</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Source</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Virus(es) Affected</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Proposed Mode of Inhibition</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Assay Used</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td rowspan="2" align="left" valign="top" style="border-bottom:solid thin" colspan="1">1</td><td rowspan="2" align="left" valign="top" style="border-bottom:solid thin" colspan="1">Baicalein<break/><inline-graphic xlink:href="molecules-25-02796-i001.jpg"/></td><td rowspan="2" align="left" valign="top" style="border-bottom:solid thin" colspan="1">Roots of <italic>Scutellaria baicalensis</italic> and <italic>Scutellaria lateriflora</italic></td><td align="center" valign="top" rowspan="1" colspan="1">CHIKV</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Inhibits viral attachment to host cells</p></list-item><list-item><label>-</label><p>Has potent virucidal activity against extracellular viral particles</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Time-of-addition assay, inactivation assay</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B95-molecules-25-02796" ref-type="bibr">95</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">JEV</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Possibly inhibits virus entry to cells</p></list-item><list-item><label>-</label><p>Has potent virucidal activity against extracellular viral particles</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Foci forming unit reduction assay, qRT-PCR</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B83-molecules-25-02796" ref-type="bibr">83</xref>]</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Baicalin (main metabolite of baicalein)<break/><inline-graphic xlink:href="molecules-25-02796-i002.jpg"/></td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Roots of <italic>Scutellaria baicalensis</italic> and <italic>Scutellaria lateriflora</italic></td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">DEN-2</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Interferes and inhibits DENV-2 in vitro replication at various stages of the virus replication cycle</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Foci reduction assay, virus yield reduction assay</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B96-molecules-25-02796" ref-type="bibr">96</xref>]</td></tr><tr><td rowspan="5" align="left" valign="top" style="border-bottom:solid thin" colspan="1">3</td><td rowspan="5" align="left" valign="top" style="border-bottom:solid thin" colspan="1">Curcumin<break/><inline-graphic xlink:href="molecules-25-02796-i003.jpg"/></td><td rowspan="5" align="left" valign="top" style="border-bottom:solid thin" colspan="1"><italic>Curcuma longa</italic> (turmeric)</td><td rowspan="2" align="center" valign="top" colspan="1">DEN-2</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Three synthesized monoketone analogues of curcumin were shown to have better antiviral activity than curcumin</p></list-item><list-item><label>-</label><p>Possibly inhibits virus by targeting host pathway essential for viral replication</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Plaque assay</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B97-molecules-25-02796" ref-type="bibr">97</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Virucidal activity on enveloped viruses</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Plaque reduction assay</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B98-molecules-25-02796" ref-type="bibr">98</xref>]</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">CHIKV</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Inhibits viral attachment to host cells</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Time-of-addition assay</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B99-molecules-25-02796" ref-type="bibr">99</xref>]</td></tr><tr><td rowspan="2" align="center" valign="top" style="border-bottom:solid thin" colspan="1">ZIKV<break/>JEV</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Inhibits viral attachment to host cells</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Time-of-addition assay</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B99-molecules-25-02796" ref-type="bibr">99</xref>]</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Virucidal activity on enveloped viruses</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Plaque reduction assay</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B98-molecules-25-02796" ref-type="bibr">98</xref>]</td></tr><tr><td rowspan="3" align="left" valign="top" colspan="1">4</td><td rowspan="3" align="left" valign="top" colspan="1">Delphinidin<break/><inline-graphic xlink:href="molecules-25-02796-i004.jpg"/></td><td rowspan="3" align="left" valign="top" colspan="1">Pigment found in various flowers and fruits</td><td align="center" valign="top" rowspan="1" colspan="1">DEN-1 to -4</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Virucidal activity observed</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Plaque assay</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B92-molecules-25-02796" ref-type="bibr">92</xref>]</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">WNV</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Affects early stages of viral replication cycle</p></list-item><list-item><label>-</label><p>Virucidal activity observed</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Plaque assay</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B92-molecules-25-02796" ref-type="bibr">92</xref>]</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">ZIKV</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Virucidal activity observed</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Plaque assay</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B92-molecules-25-02796" ref-type="bibr">92</xref>]</td></tr><tr><td rowspan="5" align="left" valign="top" style="border-top:solid thin;border-bottom:solid thin" colspan="1">5</td><td rowspan="5" align="left" valign="top" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Epigallocatechin gallate (EGCG)<break/><inline-graphic xlink:href="molecules-25-02796-i005.jpg"/></td><td rowspan="5" align="left" valign="top" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Leaves of <italic>Camellia sinensis</italic> (green tea)</td><td align="center" valign="top" style="border-top:solid thin" rowspan="1" colspan="1">DEN-1 to -4</td><td align="left" valign="top" style="border-top:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Virucidal activity observed</p></list-item></list>
</td><td align="left" valign="top" style="border-top:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Plaque assay</p></list-item></list>
</td><td align="left" valign="top" style="border-top:solid thin" rowspan="1" colspan="1">[<xref rid="B92-molecules-25-02796" ref-type="bibr">92</xref>]</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">CHIKV</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Possibly inhibits attachment to host cells</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Pseudotyping of lentiviral vectors with CHIKV glycoprotein and transduced HEK 293T cells</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B100-molecules-25-02796" ref-type="bibr">100</xref>]</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">WNV</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Affects early stages of viral replication cycle</p></list-item><list-item><label>-</label><p>Virucidal activity observed</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Plaque assay</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B92-molecules-25-02796" ref-type="bibr">92</xref>]</td></tr><tr><td rowspan="2" align="center" valign="top" style="border-bottom:solid thin" colspan="1">ZIKV</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Possibly inhibits attachment to host cells</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Pre-treatment assay</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B101-molecules-25-02796" ref-type="bibr">101</xref>]</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Virucidal activity observed</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Plaque assay</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B92-molecules-25-02796" ref-type="bibr">92</xref>]</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Fisetin<break/><inline-graphic xlink:href="molecules-25-02796-i006.jpg"/></td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Pigment found in various flowers and fruits</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">CHIKV</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Inhibits early stages of viral replication</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Time-of-addition assay</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B95-molecules-25-02796" ref-type="bibr">95</xref>]</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Harringtonine<break/><inline-graphic xlink:href="molecules-25-02796-i007.jpg"/></td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cephalotaxus harringtonia</italic> (Japanese plum yew)</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">CHIKV</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Possibly by inhibiting viral protein synthesis</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Time-of-addition assay, qRT-PCR, SDS-PAGE, western blot</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B102-molecules-25-02796" ref-type="bibr">102</xref>]</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Honokiol<break/><inline-graphic xlink:href="molecules-25-02796-i008.jpg"/></td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Bark or seed cones of Magnolia tree</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">DEN-2</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Inhibits viral entry to the host cells and suppresses in vitro viral replication</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Pre-treatment assay, viral yield reduction, and fluorescence focus formation assay</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B103-molecules-25-02796" ref-type="bibr">103</xref>]</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Isoquercitrin<break/><inline-graphic xlink:href="molecules-25-02796-i009.jpg"/></td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Various plants, including leaves of <italic>Annona squamosa</italic> (sugar apple) and <italic>Camellia sinensis</italic> (green tea)</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">ZIKV</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Inhibits viral entry to the host cell</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Time-of-addition assay</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B104-molecules-25-02796" ref-type="bibr">104</xref>]</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Kaempferol<break/><inline-graphic xlink:href="molecules-25-02796-i010.jpg"/></td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Various plant sources including tea, broccoli, grapefruit and apples</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">JEV</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Viral inactivation through binding to JEV frame-shift RNA</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>qRT-PCR</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B105-molecules-25-02796" ref-type="bibr">105</xref>]</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Naringenin<break/><inline-graphic xlink:href="molecules-25-02796-i011.jpg"/></td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Citrus fruits such as grapefruit, bergamot, and tomatoes</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">DEN-1 to -4</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Impairs DENV replication cycle</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Time-of-addition assay</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B106-molecules-25-02796" ref-type="bibr">106</xref>]</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Pinocembrin<break/><inline-graphic xlink:href="molecules-25-02796-i012.jpg"/></td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Honey, tea and red wine</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">ZIKV</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Inhibits post-entry processes of viral life cycle</p></list-item><list-item><label>-</label><p>Inhibits viral RNA production and envelope protein synthesis</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Time-of-addition and time-of-removal assays, qRT-PCR, and western blot</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B107-molecules-25-02796" ref-type="bibr">107</xref>]</td></tr><tr><td rowspan="2" align="left" valign="top" style="border-bottom:solid thin" colspan="1">13</td><td rowspan="2" align="left" valign="top" style="border-bottom:solid thin" colspan="1">Quercetin<break/><inline-graphic xlink:href="molecules-25-02796-i013.jpg"/><break/></td><td rowspan="2" align="left" valign="top" style="border-bottom:solid thin" colspan="1"><italic>Bauhinia longifolia</italic> leaves, tea, apple, onion and tomato</td><td align="center" valign="top" rowspan="1" colspan="1">DEN-2</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Inhibits intracellular viral replication but not viral attachment and entry processes</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Foci forming unit reduction assay, qRT-PCR</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B108-molecules-25-02796" ref-type="bibr">108</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">MAYV *</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Virucidal activity observed</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Virus yield inhibition assay</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B82-molecules-25-02796" ref-type="bibr">82</xref>]</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Quercetagetin<break/><inline-graphic xlink:href="molecules-25-02796-i014.jpg"/></td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Leaves of <italic>Eriocaulon</italic> species.</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">CHIKV</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Inhibits viral attachment to host cells </p></list-item><list-item><label>-</label><p>Has potent neutralizing effect against extracellular CHIKV particles</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Time-of-addition assay, inactivation assay</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B95-molecules-25-02796" ref-type="bibr">95</xref>]</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">15</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Quinine<break/><inline-graphic xlink:href="molecules-25-02796-i015.jpg"/></td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Cinchona tree</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">DEN-1 to -4</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Inhibits viral replication by reducing DENV RNA and viral protein synthesis</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Virus internalization assay, focus-forming unit (FFU) assay real time RT-PCR, western blot</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B109-molecules-25-02796" ref-type="bibr">109</xref>]</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">16</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Resveratrol<break/><inline-graphic xlink:href="molecules-25-02796-i016.jpg"/></td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Grapes and peanuts </td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">ZIKV</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Inhibits viral attachment to host cells</p></list-item><list-item><label>-</label><p>Virucidal activity observed</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Pre-treatment and post-treatment assay, focus-forming assay, qRT-PCR, anti-adsorption and virus internalization inhibition assay</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B110-molecules-25-02796" ref-type="bibr">110</xref>]</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">17</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">ST081006<break/><inline-graphic xlink:href="molecules-25-02796-i017.jpg"/></td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Synthetic flavonoid from flavonoid-derivative library</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">DEN-1 to -4</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Affects synthesis of both viral protein and RNA</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Pre-treatment, time-of-addition, and time-of-removal assays, qRT-PCR and western blot</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B111-molecules-25-02796" ref-type="bibr">111</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>* denotes arbovirus not currently circulating in Asia.</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-25-02796-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-02796-t003_Table 3</object-id><label>Table 3</label><caption><p>List of plant extracts that exhibited antiviral activity against arboviruses</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">S/N</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plant Extract (active compound)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Source</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Virus(es) Affected</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mode of Inhibition</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Assay Used</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td rowspan="2" align="left" valign="top" style="border-bottom:solid thin" colspan="1">1</td><td rowspan="2" align="left" valign="top" style="border-bottom:solid thin" colspan="1"><italic>Aphloia theiformis</italic> extract^</td><td rowspan="2" align="left" valign="top" style="border-bottom:solid thin" colspan="1">
<italic>Aphloia theiformis</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1">DEN-1 to -4</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Inhibits viral attachment to host cells</p></list-item></list>
</td><td rowspan="2" align="left" valign="top" style="border-bottom:solid thin" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Foci-forming immunodetection assay, virus inactivation assay</p></list-item></list>
</td><td rowspan="2" align="left" valign="top" style="border-bottom:solid thin" colspan="1">[<xref rid="B81-molecules-25-02796" ref-type="bibr">81</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">ZIKV</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Inhibits viral attachment to host cells</p></list-item></list>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Mushroom extracts^</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>L. rhinocerotis</italic>, <italic>P. giganteus</italic>, <italic>H. erinaceus</italic> and <italic>S. commune</italic></td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">DEN-2</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Inhibits viral attachment and entry to host cells</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Time-of-addition studies, plaque reduction assay, and RT-qPCR</p></list-item></list>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B112-molecules-25-02796" ref-type="bibr">112</xref>]</td></tr><tr><td rowspan="2" align="left" valign="top" style="border-bottom:solid thin" colspan="1">3</td><td rowspan="2" align="left" valign="top" style="border-bottom:solid thin" colspan="1"><italic>Psiloxylon mauritianum</italic> extract^</td><td rowspan="2" align="left" valign="top" style="border-bottom:solid thin" colspan="1">Aerial parts of <italic>Psiloxylon mauritianum</italic></td><td align="center" valign="top" rowspan="1" colspan="1">DEN-1 to -4</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Inhibits viral attachment to host cells</p></list-item></list>
</td><td rowspan="2" align="left" valign="top" style="border-bottom:solid thin" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Time-of-addition assay</p></list-item></list>
</td><td rowspan="2" align="left" valign="top" style="border-bottom:solid thin" colspan="1">[<xref rid="B113-molecules-25-02796" ref-type="bibr">113</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">ZIKV</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Inhibits viral attachment to host cells</p></list-item></list>
</td></tr><tr><td rowspan="2" align="left" valign="top" style="border-bottom:solid thin" colspan="1">4</td><td rowspan="2" align="left" valign="top" style="border-bottom:solid thin" colspan="1">Silymarin complex (Silybin)</td><td rowspan="2" align="left" valign="top" style="border-bottom:solid thin" colspan="1">Seeds of <italic>Silybum marianum</italic> (Milk thistle)</td><td align="center" valign="top" rowspan="1" colspan="1">CHIKV</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>In vitro antiviral activity observed</p></list-item><list-item><label>-</label><p>Inhibits post-entry stages of viral replication cycle</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Time-of-addition and time-of-removal studies, qRT-PCR and western blot</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="B114-molecules-25-02796" ref-type="bibr">114</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">MAYV *</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>In vitro antiviral activity observed</p></list-item><list-item><label>-</label><p>Protective effect against virus-induced oxidative stress</p></list-item></list>
</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>&#x02013; Plaque reduction assay, measuring reactive oxygen species production of MAYV infected cells before and after silymarin treatment</p></list-item></list>
</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B115-molecules-25-02796" ref-type="bibr">115</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>* denotes arbovirus not currently circulating in Asia. ^ denotes active compound not reported in literature.</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-25-02796-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-02796-t004_Table 4</object-id><label>Table 4</label><caption><p>Overview of the natural compounds which can inhibit the different arboviruses</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type of Inhibitors</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Antiviral Natural Compounds <sup>1</sup></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">DENV inhibitors</td><td align="center" valign="middle" rowspan="1" colspan="1">Baicalein, curcumin, delphinidin, EGCG, honokiol, naringenin, quercetin, quinine, and ST081006</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">JEV inhibitors</td><td align="center" valign="middle" rowspan="1" colspan="1">Baicalein, curcumin, and kaempferol</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">WNV inhibitors</td><td align="center" valign="middle" rowspan="1" colspan="1">Delphinidin and EGCG</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">ZIKV inhibitors</td><td align="center" valign="middle" rowspan="1" colspan="1">Curcumin, delphinidin, EGCG, isoquercitrin, pinocembrin, and resveratrol</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">CHIKV inhibitors</td><td align="center" valign="middle" rowspan="1" colspan="1">Baicalein, curcumin, EGCG, fisetin, harringtonine, and quercetagetin</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAYV inhibitor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quercetin</td></tr></tbody></table><table-wrap-foot><fn><p><sup>1</sup> Refer to <xref rid="molecules-25-02796-t002" ref-type="table">Table 2</xref> for references for the respective compounds.</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-25-02796-t005" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-02796-t005_Table 5</object-id><label>Table 5</label><caption><p>Overview of the plant extracts which can inhibit the different arboviruses</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type of Inhibitors</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Antiviral Plant Extracts <sup>1</sup></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">DENV inhibitors</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Aphloia theiformis</italic> extract, mushroom extracts and <italic>Psiloxylon mauritianum</italic> extract</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">ZIKV inhibitors</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Aphloia theiformis</italic> extract and <italic>Psiloxylon mauritianum</italic> extract</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">CHIKV inhibitors</td><td align="center" valign="middle" rowspan="1" colspan="1">Silymarin complex</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAYV inhibitor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silymarin complex</td></tr></tbody></table><table-wrap-foot><fn><p><sup>1</sup> Refer to <xref rid="molecules-25-02796-t003" ref-type="table">Table 3</xref> for references for the respective compounds.</p></fn></table-wrap-foot></table-wrap></floats-group></article>